STOCK TITAN

Launch Two holders redeem about $199M in shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Launch Two Acquisition Corp. (LPBB) reported net income of $1,390,024 for the third quarter of 2026, compared with $2,268,915 a year earlier; nine-month net income was $4,507,658, versus $6,851,780. Trust Account interest income was $2,261,800 for the quarter, compared with $2,533,302 a year earlier. On June 25, 2026, the company agreed to combine with NuCube Energy, Inc.; NuCube would become its wholly owned subsidiary if the transaction closes.

At an October 8, 2026 shareholder meeting, shareholders approved extending the combination period in monthly increments, up to six times, through April 9, 2027. Holders redeemed 18,322,071 Public Shares for approximately $198.6 million at approximately $10.84 per share, leaving 4,677,929 Public Shares outstanding.

An October 19 amendment extended the NuCube agreement’s Outside Date to January 7, 2027, at 5:00 p.m. Eastern time, and permitted NuCube to issue Series A-4 Preferred Stock before closing. The proposed combination remains subject to the agreement’s terms and conditions.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 2 points

How the balance works

Positive

  • None.

Negative

  • Major pointPost-quarter redemptions covered 18,322,071 Public Shares, for approximately $198.6 million. 64% of market cap
  • Moderate pointQuarterly net income declined to $1,390,024 from $2,268,915 a year earlier.
Third-quarter net income $1,390,024 Three months ended September 30, 2026; $2,268,915 for the same period in 2025.
Nine-month net income $4,507,658 Nine months ended September 30, 2026; $6,851,780 for the same period in 2025.
Trust Account balance $249,943,983 As of September 30, 2026.
Public Shares redeemed 18,322,071 shares October 8, 2026 shareholder meeting, after giving effect to withdrawals of redemptions.
Aggregate redemption amount Approximately $198.6 million October 8, 2026 redemptions; approximately $10.84 per Public Share.
Public Shares outstanding after redemptions 4,677,929 shares Following the October 8, 2026 redemptions.
Earnout Shares Up to 12,575,000 shares Contingent on the post-closing stock-price trigger in the NuCube agreement.
NuCube Series A-4 Preferred Stock purchase price $12.779 per share Financing terms permitted by the October 19, 2026 amendment to the NuCube agreement.
Trust Account financial
"interest earned on cash and marketable securities held in Trust Account"
A trust account is a special bank or brokerage account where assets are held and managed by a designated person or firm (the trustee) for the benefit of another person or group (the beneficiary). It matters to investors because it separates assets from personal or corporate funds, can protect assets, control how and when money is used, and may affect tax or legal rights—think of it as a locked drawer opened only under agreed rules.
Outside Date technical
"extend the Outside Date to January 7, 2027"
An outside date is the final contractual deadline by which a planned deal—such as a merger, acquisition, or financing—must be completed; if the transaction hasn’t closed by that date, parties typically gain the right to walk away or trigger agreed remedies. It matters to investors because it sets a clear timetable for when uncertainty should end, and approaching or missing the outside date can raise the chance of deal failure, renegotiation, or changes to valuation.
Earnout Shares financial
"up to 12,575,000 additional shares of SPAC Common Stock"
Earnout shares are company stock promised to sellers as part of an acquisition that only becomes payable if the acquired business hits agreed future performance targets, like revenue or profit goals. They matter to investors because they can increase the number of shares outstanding (dilution), tie seller incentives to future success, and create uncertainty about the actual cost of the deal and future ownership unless the performance conditions are clearly understood.
volume weighted average price financial
"the volume weighted average price of SPAC Common Stock"
The volume weighted average price (VWAP) is a way to measure the average price of a security, such as a stock, over a specific period, taking into account how many units were traded at each price. It’s similar to calculating the average cost of items bought when some are more frequently purchased than others. Investors use VWAP to assess whether a security is being bought or sold at a fair price during trading.
debt discount financial
"the $98,000 difference between the principal amount and the $750,000 of cash proceeds"
The shortfall between a debt instrument’s face (par) value and the lower price at which it is sold or traded. When debt is issued or traded at a discount, the buyer pays less than the amount that will be repaid at maturity; that discount implies a higher effective yield to the buyer than the stated coupon and, for accounting, is amortized over the life of the debt (or recorded as a loss if the discount reflects a negotiated reduction in repayment).
temporary equity financial
"presented at redemption value as temporary equity"
Equity-like securities that accounting rules require to be reported separately from permanent shareholders’ equity because the holder can force or the issuer is obligated to settle them in cash or other assets (or they will be settled on a specified date). Examples include mandatorily redeemable shares and certain convertible instruments with required cash settlement; on the balance sheet they appear between liabilities and shareholders’ equity (often called mezzanine or temporary equity) rather than as part of common equity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LPBB shares were redeemed in October 2026?

At the October 8, 2026 meeting, holders redeemed 18,322,071 Public Shares for approximately $198.6 million, at approximately $10.84 per share, after giving effect to withdrawals of redemption requests. Following the redemptions, 4,677,929 Public Shares were outstanding.

What are the conditions for NuCube shareholders to receive earnout shares?

The NuCube agreement provides for up to 12,575,000 additional shares if, during the three years following closing, the volume weighted average price of SPAC Common Stock equals or exceeds $18.00 per share for at least 20 trading days within a consecutive 30 trading day period. If achieved, half the shares are released 90 days after confirmation and the remainder 180 days after that determination date; otherwise, they are forfeited.

What NuCube financing did LPBB's October 2026 agreement amendment permit?

The amendment permits NuCube to enter into securities purchase agreements before closing for Series A-4 Preferred Stock. The stated terms provide for a $12.779 per-share purchase price, a 1:1 conversion ratio and 50% warrant coverage, with an exercise price of $15.887 per warrant share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
http://fasb.org/srt/2026#ChiefFinancialOfficerMember CA 1 1 P5Y P3D P5Y 0002023676 false Q3 --12-31 0002023676 2026-07-01 2026-09-30 0002023676 us-gaap:SubsequentEventMember 2026-10-19 0002023676 us-gaap:SubsequentEventMember lpbb:NuCubeBCAMember 2026-10-19 0002023676 us-gaap:SubsequentEventMember srt:MaximumMember 2026-10-19 0002023676 us-gaap:SubsequentEventMember srt:MinimumMember 2026-10-19 0002023676 us-gaap:SubsequentEventMember us-gaap:CommonClassAMember 2026-10-08 2026-10-08 0002023676 us-gaap:SubsequentEventMember lpbb:Non-RedeemedSharesMember us-gaap:CommonClassAMember 2026-10-08 2026-10-08 0002023676 us-gaap:SubsequentEventMember lpbb:PublicSharesMember 2026-10-08 0002023676 us-gaap:SubsequentEventMember 2026-10-08 0002023676 2026-01-01 2026-09-30 0002023676 2025-01-01 2025-09-30 0002023676 2025-07-01 2025-09-30 0002023676 2025-12-31 0002023676 2026-09-30 0002023676 us-gaap:USTreasurySecuritiesMember 2025-12-31 0002023676 us-gaap:CashMember 2025-12-31 0002023676 us-gaap:USTreasurySecuritiesMember 2026-09-30 0002023676 us-gaap:CashMember 2026-09-30 0002023676 us-gaap:CommonClassAMember 2026-01-01 2026-09-30 0002023676 us-gaap:CommonClassAMember srt:MaximumMember 2026-01-01 2026-09-30 0002023676 us-gaap:CommonClassAMember srt:MinimumMember 2026-01-01 2026-09-30 0002023676 us-gaap:CommonClassAMember us-gaap:WarrantMember 2026-09-30 0002023676 us-gaap:CommonClassAMember 2026-09-30 0002023676 us-gaap:WarrantMember 2026-01-01 2026-09-30 0002023676 srt:MaximumMember 2026-01-01 2026-09-30 0002023676 srt:MinimumMember 2026-01-01 2026-09-30 0002023676 us-gaap:CommonClassAMember 2025-12-31 0002023676 us-gaap:PrivatePlacementMember 2025-12-31 0002023676 us-gaap:PrivatePlacementMember 2026-09-30 0002023676 lpbb:PublicWarrantsMember 2025-12-31 0002023676 lpbb:PublicWarrantsMember 2026-09-30 0002023676 us-gaap:WarrantMember 2025-12-31 0002023676 us-gaap:WarrantMember 2026-09-30 0002023676 srt:DirectorMember 2026-01-01 2026-09-30 0002023676 us-gaap:CommonClassBMember 2026-01-01 2026-09-30 0002023676 us-gaap:CommonClassAMember lpbb:SponsorMember 2026-09-30 0002023676 us-gaap:CommonClassBMember 2025-12-31 0002023676 us-gaap:CommonClassBMember 2026-09-30 0002023676 lpbb:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2025-12-31 0002023676 lpbb:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2026-09-30 0002023676 us-gaap:OverAllotmentOptionMember 2026-09-30 0002023676 us-gaap:IPOMember 2026-09-30 0002023676 us-gaap:OverAllotmentOptionMember 2024-10-09 0002023676 us-gaap:OverAllotmentOptionMember 2024-10-09 2024-10-09 0002023676 us-gaap:OverAllotmentOptionMember 2026-01-01 2026-09-30 0002023676 lpbb:ConsultingAgreementMember 2026-08-17 0002023676 lpbb:FounderShareMember lpbb:ConsultingAgreementMember 2026-08-17 2026-08-17 0002023676 lpbb:SponsorMember lpbb:FounderShareMember 2026-01-01 2026-09-30 0002023676 lpbb:FounderSharesMember 2026-09-30 0002023676 lpbb:SponsorMember 2026-01-01 2026-09-30 0002023676 lpbb:CreditPledgeAndConsultingAgreementsMember 2026-09-30 0002023676 2026-09-30 2026-09-30 0002023676 lpbb:WorkingCapitalNoteMember 2026-09-30 0002023676 lpbb:WorkingCapitalNoteMember 2026-01-01 2026-09-30 0002023676 2026-08-17 0002023676 2026-08-17 2026-08-17 0002023676 lpbb:WorkingCapitalNoteMember 2026-08-17 2026-08-17 0002023676 lpbb:WorkingCapitalNoteMember 2026-08-07 0002023676 lpbb:SponsorMember lpbb:WorkingCapitalNoteMember 2026-08-07 2026-08-07 0002023676 lpbb:SponsorMember lpbb:WorkingCapitalNoteMember 2026-08-07 2026-08-07 0002023676 lpbb:SponsorMember lpbb:WorkingCapitalNoteMember 2026-08-17 2026-08-17 0002023676 lpbb:AdministrativeServicesAgreementMember 2026-01-01 2026-09-30 0002023676 lpbb:AdministrativeServicesAgreementMember 2024-10-07 2024-10-07 0002023676 lpbb:SponsorMember 2026-01-01 2026-09-30 0002023676 lpbb:PromissoryNoteRelatedPartyMember lpbb:SponsorMember 2026-09-30 0002023676 us-gaap:CommonClassAMember lpbb:FoundersSharesMember 2026-01-01 2026-09-30 0002023676 lpbb:FounderShares1Member 2024-10-09 2024-10-09 0002023676 us-gaap:OverAllotmentOptionMember lpbb:SponsorMember 2024-05-13 2024-05-13 0002023676 us-gaap:CommonClassBMember lpbb:FounderShares1Member 2024-05-13 2024-05-13 0002023676 lpbb:SponsorMember 2024-05-13 0002023676 lpbb:SponsorMember 2024-05-13 2024-05-13 0002023676 2024-10-09 0002023676 lpbb:PrivatePlacementWarrantMember lpbb:CantorMember 2024-10-09 0002023676 lpbb:PrivatePlacementWarrantMember lpbb:SponsorMember 2024-10-09 0002023676 lpbb:PrivatePlacementWarrantMember 2024-10-09 0002023676 us-gaap:PrivatePlacementMember 2024-10-09 2024-10-09 0002023676 lpbb:PrivatePlacementWarrantMember us-gaap:WarrantMember 2024-10-09 0002023676 us-gaap:CommonClassAMember 2024-10-09 0002023676 us-gaap:CommonClassAMember us-gaap:WarrantMember 2024-10-09 0002023676 lpbb:RedeemablePublicWarrantMember 2024-10-09 2024-10-09 0002023676 us-gaap:CommonClassAMember 2024-10-09 2024-10-09 0002023676 us-gaap:IPOMember 2024-10-09 2024-10-09 0002023676 lpbb:NonredeemableSharesMember 2025-01-01 2025-09-30 0002023676 lpbb:RedeemableSharesMember 2025-01-01 2025-09-30 0002023676 lpbb:NonredeemableSharesMember 2026-01-01 2026-09-30 0002023676 lpbb:RedeemableSharesMember 2026-01-01 2026-09-30 0002023676 lpbb:NonredeemableSharesMember 2025-07-01 2025-09-30 0002023676 lpbb:RedeemableSharesMember 2025-07-01 2025-09-30 0002023676 lpbb:NonredeemableSharesMember 2026-07-01 2026-09-30 0002023676 lpbb:RedeemableSharesMember 2026-07-01 2026-09-30 0002023676 lpbb:PrivateWarrantsMember 2026-09-30 0002023676 lpbb:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2026-01-01 2026-09-30 0002023676 lpbb:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2026-06-30 0002023676 lpbb:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2026-04-01 2026-06-30 0002023676 lpbb:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2026-03-31 0002023676 lpbb:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2026-01-01 2026-03-31 0002023676 lpbb:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2025-01-01 2025-12-31 0002023676 lpbb:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2024-12-31 0002023676 lpbb:SponsorMember 2026-01-01 2026-09-30 0002023676 lpbb:SponsorMember lpbb:FounderSharesMember 2024-10-09 2024-10-09 0002023676 lpbb:SPACCommonStockMember 2026-09-30 0002023676 lpbb:SPACCommonStockMember 2026-01-01 2026-09-30 0002023676 lpbb:CompanyCommonStockMember 2026-09-30 0002023676 lpbb:TrustAccountMember 2026-09-30 0002023676 us-gaap:IPOMember lpbb:TrustAccountMember 2026-09-30 0002023676 2024-10-09 2024-10-09 0002023676 lpbb:TrustAccountMember 2024-10-09 0002023676 lpbb:TrustAccountMember 2024-10-09 2024-10-09 0002023676 lpbb:SponsorMember lpbb:PrivatePlacementWarrantsMember 2024-10-09 0002023676 lpbb:PrivatePlacementWarrantsMember lpbb:CantorFitzgeraldCoMember 2024-10-09 0002023676 lpbb:PrivatePlacementWarrantsMember lpbb:SponsorMember 2024-10-09 0002023676 lpbb:PrivatePlacementWarrantsMember 2024-10-09 0002023676 lpbb:PrivatePlacementWarrantsMember us-gaap:WarrantMember 2024-10-09 0002023676 us-gaap:CommonClassAMember us-gaap:IPOMember 2024-10-09 2024-10-09 0002023676 2025-09-30 0002023676 2024-12-31 0002023676 us-gaap:RetainedEarningsMember 2025-09-30 0002023676 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-09-30 0002023676 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0002023676 2025-06-30 0002023676 us-gaap:RetainedEarningsMember 2025-06-30 0002023676 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-06-30 0002023676 2025-04-01 2025-06-30 0002023676 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0002023676 2025-03-31 0002023676 us-gaap:RetainedEarningsMember 2025-03-31 0002023676 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-03-31 0002023676 2025-01-01 2025-03-31 0002023676 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0002023676 us-gaap:RetainedEarningsMember 2024-12-31 0002023676 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-12-31 0002023676 us-gaap:RetainedEarningsMember 2026-09-30 0002023676 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-09-30 0002023676 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-09-30 0002023676 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0002023676 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-07-01 2026-09-30 0002023676 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-07-01 2026-09-30 0002023676 2026-06-30 0002023676 us-gaap:RetainedEarningsMember 2026-06-30 0002023676 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-06-30 0002023676 2026-04-01 2026-06-30 0002023676 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0002023676 2026-03-31 0002023676 us-gaap:RetainedEarningsMember 2026-03-31 0002023676 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-03-31 0002023676 2026-01-01 2026-03-31 0002023676 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0002023676 us-gaap:RetainedEarningsMember 2025-12-31 0002023676 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-12-31 0002023676 lpbb:Non-RedeemableClassAAndClassBOrdinarySharesMember 2025-01-01 2025-09-30 0002023676 lpbb:Non-RedeemableClassAAndClassBOrdinarySharesMember 2026-01-01 2026-09-30 0002023676 lpbb:Non-RedeemableClassAAndClassBOrdinarySharesMember 2025-07-01 2025-09-30 0002023676 lpbb:Non-RedeemableClassAAndClassBOrdinarySharesMember 2026-07-01 2026-09-30 0002023676 lpbb:ClassARedeemableOrdinarySharesMember 2025-01-01 2025-09-30 0002023676 lpbb:ClassARedeemableOrdinarySharesMember 2026-01-01 2026-09-30 0002023676 lpbb:ClassARedeemableOrdinarySharesMember 2025-07-01 2025-09-30 0002023676 lpbb:ClassARedeemableOrdinarySharesMember 2026-07-01 2026-09-30 0002023676 us-gaap:CommonClassBMember 2026-11-13 0002023676 us-gaap:CommonClassAMember 2026-11-13 0002023676 lpbb:WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150PerShareMember 2026-01-01 2026-09-30 0002023676 lpbb:ClassAOrdinarySharesParValue00001PerShareMember 2026-01-01 2026-09-30 0002023676 lpbb:UnitsEachConsistingOfOneClassAOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember 2026-01-01 2026-09-30 0002023676 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-12-31 0002023676 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0002023676 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-01-01 2026-03-31 0002023676 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-01-01 2026-03-31 0002023676 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0002023676 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-03-31 0002023676 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0002023676 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-04-01 2026-06-30 0002023676 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-04-01 2026-06-30 0002023676 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0002023676 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-06-30 0002023676 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-12-31 0002023676 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0002023676 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-01-01 2025-03-31 0002023676 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-01-01 2025-03-31 0002023676 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0002023676 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-03-31 0002023676 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0002023676 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-04-01 2025-06-30 0002023676 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-04-01 2025-06-30 0002023676 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0002023676 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-06-30 0002023676 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0002023676 lpbb:SponsorMember 2026-09-30 0002023676 lpbb:SponsorMember 2025-12-31 0002023676 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0002023676 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0002023676 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-07-01 2025-09-30 0002023676 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-07-01 2025-09-30 0002023676 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0002023676 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0002023676 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-09-30 0002023676 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0002023676 lpbb:PrivatePlacementWarrantMember 2026-09-30 iso4217:USD xbrli:shares xbrli:pure xbrli:shares iso4217:USD lpbb:Segment

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended September 30, 2026
 
or
 
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from                  to                  

 

Commission File Number: 001-42306

 

Launch Two Acquisition Corp.

(Exact name of registrant as specified in its charter)

 

Cayman Islands   98-1801568
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

180 Grand Avenue
Suite 1530
Oakland, California
  94612
(Address of principal executive offices)   (Zip Code)

 

(510) 692-9600

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one Class A Ordinary Share and one-half of one redeemable Warrant   LPBBU   The Nasdaq Stock Market LLC
         
Class A Ordinary Shares, par value $0.0001 per share   LPBB   The Nasdaq Stock Market LLC
         
Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share   LPBBW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒   No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒   No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer ☐  Accelerated filer ☐ 
  Non-accelerated filer ☒  Smaller reporting company ☒ 
    Emerging growth company ☒ 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒   No ☐

 

As of November 13, 2026, there were 10,427,928 Class A Ordinary Shares, par value $0.0001 per share, and one Class B Ordinary Share, par value $0.0001 per share, of the registrant issued and outstanding.

 

 

 

 

 

 

LAUNCH TWO ACQUISITION CORP.

 

FORM 10-Q FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2026

 

TABLE OF CONTENTS

 

      Page
PART I – FINANCIAL INFORMATION   1
       
Item 1. Financial Statements.   1
       
  Condensed Consolidated Balance Sheets as of September 30, 2026 (Unaudited) and December 31, 2025   1
       
  Unaudited Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2026 and 2025   2
       
  Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Deficit for the Three and Nine Months Ended September 30, 2026 and 2025   3
       
  Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2026 and 2025   4
       
  Notes to Unaudited Condensed Consolidated Financial Statements   5
       
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.   22
       
Item 3. Quantitative and Qualitative Disclosures About Market Risk.   30
       
Item 4. Controls and Procedures.   30
       
PART II – OTHER INFORMATION   31
       
Item 1. Legal Proceedings.   31
       
Item 1A. Risk Factors.   31
       
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.   31
       
Item 3. Defaults Upon Senior Securities.   32
       
Item 4. Mine Safety Disclosures.   32
       
Item 5. Other Information.   32
       
Item 6. Exhibits.   33
       
SIGNATURES   34

 

i

 

 

Unless otherwise stated in this Report (as defined below), or the context otherwise requires, references to:

 

  ● “2024 Annual Report” are to our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, as filed with the SEC (as defined below) on March 25, 2025;
     
  ●  “2025 Annual Report” are to our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as filed with the SEC on March 27, 2026;
     
  ● “2025 First Quarter Form 10-Q” are to our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025, as filed with the SEC on May 13, 2025;
     
  ● “2025 Second Quarter Form 10-Q” are to our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025, as filed with the SEC on August 14, 2025;
     
  ● “Administrative Services Agreement” are to the Administrative Services Agreement, dated October 7, 2024, which we entered into with an affiliate of our Sponsor (as defined below);

 

  ● “Amended and Restated Articles” are to our Amended and Restated Memorandum and Articles of Association, as currently in effect;

 

●“ASC” are to the FASB (as defined below) Accounting Standards Codification;

 

●“ASU” are to the FASB Accounting Standards Update;

  

●“Board of Directors” or “Board” are to our board of directors;

 

●“Business Combination” are to a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses;

 

●“Cantor” are to Cantor Fitzgerald & Co., the representative of the Underwriters (as defined below);

 

●“Certifying Officers” are to our Chief Executive Officer and Chief Financial Officer, together;

 

●“Class A Ordinary Shares” are to our Class A ordinary shares, par value $0.0001 per share;

 

●“Class B Ordinary Shares” are to our Class B ordinary shares, par value $0.0001 per share;

 

●“Combination Period” are to (i) the 30-month period, from the closing of the Initial Public Offering (as defined below) to April 9, 2027 (or such earlier date as determined by the Board), as extended by the Extension Amendment Proposal (as defined below), that we have to consummate an initial Business Combination, or (ii) such other period in which we must consummate an initial Business Combination pursuant to an amendment to the Amended and Restated Articles and consistent with applicable laws, regulations and stock exchange rules;

  

●“Company,” “our,” “we,” or “us” are to Launch Two Acquisition Corp., a Cayman Islands exempted company;

 

ii

 

 

●“Continental” are to Continental Stock Transfer & Trust Company, trustee of our Trust Account and warrant agent of our Warrants (as defined below);

 

●“Deferred Fee” are to the additional aggregate fee of $10,950,000 to which the Underwriters are entitled that is payable only upon our completion of the initial Business Combination;

 

●“EGM” are to our extraordinary general meeting in lieu of an annual general meeting of shareholders held on October 8, 2026;

 

●“EGM Redemptions” are to the 18,322,071 Public Shares (as defined below) whose holders properly exercised their right to redeem their Public Shares for cash at a redemption price of approximately $10.84 per Public Share in connection with the approval of the Extension Amendment Proposal;

  

●“Exchange Act” are to the Securities Exchange Act of 1934, as amended;

 

●“Extension Amendment Proposal” are to the proposal at the EGM to extend the end of the Combination Period on a monthly basis, up to six (6) times, from October 9, 2026 to April 9, 2027 (or such earlier date as determined by the Board);

  

●“FASB” are to the Financial Accounting Standards Board;

 

●“Founder Share Conversion” are to the 5,749,999 Class A Ordinary Shares issued on September 30, 2026 to the Sponsor upon the conversion of an equal number of Class B Ordinary Shares held by the Sponsor as Founder Shares (as defined below);

 

●“Founder Shares” are to the (i) Class B Ordinary Shares initially purchased by our Sponsor prior to the Initial Public Offering and (ii) Class A Ordinary Shares that were issued in connection with the Founder Share Conversion upon the conversion of an equal number of Class B Ordinary Shares; for the avoidance of doubt, such Class A Ordinary Shares will not be “Public Shares”;

 

●“GAAP” are to the accounting principles generally accepted in the United States of America;

  

●“Initial Public Offering” or “IPO” are to the initial public offering that we consummated on October 9, 2024;

 

●“Investment Company Act” are to the Investment Company Act of 1940, as amended;

 

●“IPO Promissory Note” are to that certain unsecured promissory note in the principal amount of up to $300,000 issued to our Sponsor on May 13, 2024;

 

●“IPO Registration Statement” are to the Registration Statement on Form S-1 initially filed with the SEC on July 24, 2024, as amended, and declared effective on October 7, 2024 (File No. 333-280965);

 

●“Letter Agreement” are to the Letter Agreement, dated October 7, 2024, which we entered into with our Sponsor and our directors and officers;

 

●“Merger Sub” are to Tesseract Merger Sub Inc., a Delaware corporation and our wholly-owned subsidiary;

 

  ● “Management” or our “Management Team” are to our executive officers and directors;

 

  ● “Nasdaq” are to The Nasdaq Stock Market LLC;
     
  ● “Nasdaq 36-Month Requirement” are to the requirement pursuant to the Nasdaq Rules (as defined below) that a SPAC (as defined below) must complete one or more Business Combinations within 36 months following the effectiveness of its initial public offering registration statement;

 

iii

 

 

●“Nasdaq Rules” are to the continued listing rules of Nasdaq, as they exist as of the date of this Report;

 

●“Non-Redemption Agreements” are to the Non-Redemption Agreements we entered into with our Sponsor and unaffiliated, third-party investors in exchange for such investors agreeing not to redeem the Non-Redeemed Shares (as defined below) at the EGM;

 

●“Non-Redeemed Shares” are to the 4,481,851 Public Shares that were not redeemed at the EGM pursuant to the Non-Redemption Agreements;

 

●“NuCube” are to NuCube Energy, Inc., a Delaware corporation;

 

●“NuCube BCA” are to the Business Combination Agreement, dated as of June 25, 2026 and as amended by the NuCube BCA First Amendment (as defined below), which we entered into with (i) NuCube, (ii) Merger Sub (iii) the SPAC Representative (as defined below) and (iv) the Seller Representative (as defined below);

 

●“NuCube BCA First Amendment” are to Amendment No. 1 to the Business Combination Agreement, dated as of October 19, 2026, which we entered into with (i) NuCube, (ii) Merger Sub (iii) the SPAC Representative and (iv) the Seller Representative;

 

●“NuCube Business Combination” are to the transactions contemplated by the NuCube BCA and the related ancillary documents, collectively;

 

●“NuCube Form 8-Ks” are to our Current Reports on Form 8-K, as filed with the SEC on June 30, 2026 and October 20, 2026, together;

 

●“NuCube Registration Statement” are to the Registration Statement on Form S-4 in connection with the NuCube Business Combination, which was initially with the SEC on September 11, 2025 (File No. 333-298907), as may be amended, and includes a preliminary proxy statement/prospectus of our Company;

 

●“Option Units” are to the additional 3,000,000 units that the Underwriters could purchase pursuant to the Over-Allotment Option (as defined below), which was fully exercised;

 

●“Ordinary Shares” are to the Class A Ordinary Shares and the Class B Ordinary Shares, together;

 

●“Over-Allotment Option” are to the 45-day option that the Underwriters had to purchase up to an additional 3,000,000 Option Units to cover over-allotments, if any, pursuant to the Underwriting Agreement (as defined below), which was fully exercised;

  

●“Private Placement” are to the private placement of Private Placement Warrants (as defined below) that occurred simultaneously with the closing of our Initial Public Offering, pursuant to the Private Placement Warrants Purchase Agreements (as defined below);

 

●“Private Placement Warrants” are to the warrants issued to our Sponsor and Cantor in the Private Placement;

 

●“Private Placement Warrants Purchase Agreements” are to the (i) Private Placement Warrants Purchase Agreement, dated October 7, 2024, which we entered into with our Sponsor and (ii) Private Placement Warrants Purchase Agreement, dated October 7, 2024, which we entered into with Cantor, together;

 

●“Public Shareholders” are to the holders of our Public Shares, including our Sponsor and Management Team to the extent our Sponsor and/or the members of our Management Team purchase Public Shares, provided that our Sponsor’s and each member of our Management Team’s status as a “Public Shareholder” will only exist with respect to such Public Shares;

 

●“Public Shares” are to the Class A Ordinary Shares included as part of the Units (as defined below) (whether they were purchased in our Initial Public Offering or thereafter in the open market);

 

iv

 

 

●“Public Warrants” are to the redeemable warrants included as part of the Units (whether they were purchased in our Initial Public Offering or thereafter in the open market);

 

●“Registration Rights Agreement” are to the Registration Rights Agreement, dated October 7, 2024, which we entered into with the Sponsor and the other holders party thereto;

 

●“Report” are to this Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026;

 

●“SEC” are to the U.S. Securities and Exchange Commission;

 

●“Securities Act” are to the Securities Act of 1933, as amended;

 

●“Seller Representative” are to IdealabAZ, Inc., a Delaware corporation, in the capacity as representative, from and after the Effective Time (as defined in the BCA), for the NuCube’s stockholders as of immediately prior to the Effective Time;

 

●“SPAC” are to a special purpose acquisition company;

 

●“SPAC Representative” are to our Chief Executive Officer, Jay McEntee, in the capacity as the representative, from and after the Effective Time, for our shareholders as of immediately prior to the Effective Time and their successors and assigns (other than NuCube’s stockholders);

 

●“Sponsor” are to Launch Two Sponsor LLC, Delaware limited liability company;

 

●“Trust Account” are to the U.S.-based trust account in which an amount of $231,150,000 from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement Warrants in the Private Placement was placed following the closing of the Initial Public Offering;

 

  ● “Trust Agreement” are to the Investment Management Trust Agreement, dated October 7, 2024, which we entered into with Continental, as trustee of the Trust Account;
     
  ● “Underwriters” are to the several underwriters of the Initial Public Offering, collectively;

 

●“Underwriting Agreement” are to the Underwriting Agreement, dated October 7, 2024, which we entered into with Cantor, as representative of the Underwriters;

 

●“Units” are to the units sold in our Initial Public Offering, which consist of one Public Share and one-half of one Public Warrant;

  

●“Warrants” are to the Private Placement Warrants and the Public Warrants, together;

  

●“Working Capital Loans” are to funds that, in order to provide working capital or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of our directors and officers may, but are not obligated to, loan us; and

 

●“Working Capital Note” are to that certain promissory note in the principal amount of $848,000 issued to our Sponsor.

 

v

 

 

PART I – FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

LAUNCH TWO ACQUISITION CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

    September 30,
2026
    December 31,  
    (Unaudited)     2025  
ASSETS            
Current assets            
Cash   $ 222,351     $ 250,079  
Prepaid expenses     26,380       109,455  
Total current assets     248,731       359,534  
Cash and marketable securities held in Trust Account     249,943,983       243,358,236  
TOTAL ASSETS   $ 250,192,714     $ 243,717,770  
LIABILITIES AND SHAREHOLDERS’ DEFICIT                
Current liabilities                
Accrued expenses   $ 1,350,052     $ 156,201  
Working Capital Note – related party     773,435       —  
Total current liabilities     2,123,487       156,201  
Deferred Fee payable     10,950,000       10,950,000  
TOTAL LIABILITIES     13,073,487       11,106,201  
                 
COMMITMENTS AND CONTINGENCIES (Note 6)                
                 
Class A Ordinary Shares subject to possible redemption, 23,000,000 shares at redemption value of $10.87 and $10.58 per share at September 30, 2026 and December 31, 2025, respectively     249,943,983       243,358,236  
                 
SHAREHOLDERS’ DEFICIT                
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding at September 30, 2026 and December 31, 2025, respectively     —       —  
Class A Ordinary Shares, $0.0001 par value; 500,000,000 shares authorized; 5,749,999 and none issued and outstanding (excluding 23,000,000 shares subject to possible redemption) as of September 30, 2026 and December 31, 2025, respectively     575       —  
Class B Ordinary Shares, $0.0001 par value; 50,000,000 shares authorized; 1 and 5,750,000 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively     —       575  
Additional paid-in capital     —       —  
Accumulated deficit     (12,825,331 )     (10,747,242 )
TOTAL SHAREHOLDERS’ DEFICIT     (12,824,756 )     (10,746,667 )
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT   $ 250,192,714     $ 243,717,770  

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

1

 

 

LAUNCH TWO ACQUISITION CORP.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

    For the Three Months Ended
September 30,
    For the Nine Months Ended
September 30,
 
    2026     2025     2026     2025  
General and administrative costs   $ 848,355     $ 238,860     $ 2,054,687     $ 622,233  
Loss from operations     (848,355 )     (238,860 )     (2,054,687 )     (622,233 )
                                 
Other income (expense):                                
Interest earned on bank account     14       152       33       563  
Interest earned on cash and marketable securities held in Trust Account     2,261,800       2,533,302       6,585,747       7,473,450  
Interest expense     (23,435 )     —       (23,435 )     —  
Unrealized gain (loss) on cash and marketable securities held in Trust Account     —       (25,679 )     —       —  
Total other income, net     2,238,379       2,507,775       6,562,345       7,474,013  
                                 
Net income   $ 1,390,024     $ 2,268,915     $ 4,507,658     $ 6,851,780  
                                 
Basic and diluted weighted average shares outstanding of redeemable Class A Ordinary Shares     23,000,000       23,000,000       23,000,000       23,000,000  
Basic and diluted net income per ordinary share, redeemable Class A Ordinary Shares   $ 0.05     $ 0.08     $ 0.16     $ 0.24  
Basic and diluted weighted average shares outstanding of non-redeemable Class A and Class B Ordinary Shares     5,750,000       5,750,000       5,750,000       5,750,000  
Basic and diluted net income per share, non-redeemable Class A and Class B Ordinary Shares   $ 0.05     $ 0.08     $ 0.16     $ 0.24  

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

2

 

 

LAUNCH TWO ACQUISITION CORP.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

 

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026

 

    Class A
Ordinary Shares
    Class B
Ordinary Shares
    Additional
Paid-in
    Accumulated     Total
Shareholders’
 
    Shares     Amount     Shares     Amount     Capital     Deficit     Deficit  
Balance – December 31, 2025     —     $ —       5,750,000     $ 575     $ —     $ (10,747,242 )   $ (10,746,667 )
                                                         
Accretion for Class A Ordinary Shares to redemption value     —           —       —       —       —       (2,149,376 )     (2,149,376 )
                                                         
Net income     —       —       —       —       —       1,954,863       1,954,863  
                                                         
Balance – March 31, 2026 (Unaudited)     —       —       5,750,000       575       —       (10,941,755 )     (10,941,180 )
                                                         
Accretion for Class A Ordinary Shares to redemption value     —       —       —       —       —       (2,174,571 )     (2,174,571 )
                                                         
Net income     —       —       —       —       —       1,162,771       1,162,771  
                                                         
Balance – June 30, 2026 (Unaudited)     —       —       5,750,000       575       —       (11,953,555 )     (11,952,980 )
                                                         
Accretion for Class A Ordinary Shares to redemption value     —       —       —       —           —       (2,261,800 )     (2,261,800 )
                                                         
Conversion of Class B Ordinary Shares to Class A Ordinary Shares     5,749,999       575       (5,749,999 )     (575 )     —       —       —  
                                                         
Net income     —       —       —       —       —       1,390,024       1,390,024  
                                                         
Balance – September 30, 2026 (Unaudited)     5,749,999     $ 575       1     $ —     $ —     $ (12,825,331 )   $ (12,824,756 )

 

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025

 

    Class A
Ordinary Shares
    Class B
Ordinary Shares
    Additional
Paid-in
    Accumulated     Total
Shareholders’
 
    Shares     Amount     Shares     Amount     Capital     Deficit     Deficit  
Balance – December 31, 2024     —     $ —       5,750,000     $ 575     $ —     $ (9,838,851 )   $ (9,838,276 )
                                                         
Accretion for Class A Ordinary Shares to redemption value     —       —       —       —       —       (2,423,525 )     (2,423,525 )
                                                         
Net income     —       —       —       —       —       2,215,852       2,215,852  
                                                         
Balance – March 31, 2025 (Unaudited)     —       —       5,750,000       575       —       (10,046,524 )     (10,045,949 )
                                                         
Accretion for Class A Ordinary Shares to redemption value     —       —       —       —       —       (2,542,302 )     (2,542,302 )
                                                         
Net income     —       —       —       —       —       2,367,013       2,367,013  
                                                         
Balance – June 30, 2025 (Unaudited)     —       —       5,750,000       575       —       (10,221,813 )     (10,221,238 )
                                                         
Accretion for Class A Ordinary Shares to redemption value     —       —       —       —       —       (2,507,623 )     (2,507,623 )
                                                         
Net income     —       —       —       —       —       2,268,915       2,268,915  
                                                         
Balance – September 30, 2025 (Unaudited)     —     $ —       5,750,000     $ 575     $        —     $ (10,460,521 )   $ (10,459,946 )

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3

 

 

LAUNCH TWO ACQUISITION CORP.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

    For the Nine Months Ended
September 30,
 
    2026     2025  
Cash Flows from Operating Activities:            
Net income   $ 4,507,658     $ 6,851,780  
Adjustments to reconcile net income to net cash used in operating activities:                
Interest earned on cash and marketable securities held in Trust Account     (6,585,747 )     (7,473,450 )
Unrealized gain on marketable securities held in Trust Account     —       —  
Amortization of debt discount on Working Capital Note – related party     23,435       —  
Changes in operating assets and liabilities:                
Prepaid expenses     83,075       50,967  
Long-term prepaid insurance     —       70,495  
Accrued expenses     1,193,851       65,103  
Net cash used in operating activities     (777,728 )     (435,105 )
                 
Cash Flows from Financing Activities:                
Proceeds from Working Capital Note – related party     750,000       —  
Net cash provided by financing activities     750,000       —  
                 
Net Change in Cash     (27,728 )     (435,105 )
Cash – Beginning of period     250,079       935,701  
Cash – End of period   $ 222,351     $ 500,596  
                 
Supplemental disclosure of non-cash financing activities:                
Debt discount on Working Capital Note – related party   $ 98,000     $ —  
Conversion of Class B Ordinary Shares to Class A Ordinary Shares     575       —  

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

4

 

 

LAUNCH TWO ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

 

Launch Two Acquisition Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on May 13, 2024. The Company was incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company may pursue an initial Business Combination in any business or industry. On June 25, 2026, the Company entered into the NuCube BCA (as defined and described below). The Company is an early-stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early-stage and emerging growth companies.

 

The Company has a wholly-owned subsidiary that was formed on May 18, 2026, Tesseract Merger Sub, Inc. (“Merger Sub”), a Delaware corporation. The transactions contemplated by the NuCube BCA (collectively, with the related ancillary documents, the “NuCube Business Combination”) are intended to serve as the Company’s initial Business Combination.

 

As of September 30, 2026, the Company had not commenced any operations. All activities for the period from May 13, 2024 (inception) through September 30, 2026 relate to the Company’s formation, and since the Initial Public Offering (as defined below), and subsequent to the Initial Public Offering, identifying a target company and negotiating the terms of and consummating a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income on investments from the proceeds derived from the Initial Public Offering , which are held in the Trust Account (as defined below). The Company has selected December 31 as its fiscal year end.

 

The Registration Statement on Form S-1 for the Initial Public Offering, initially filed with the U.S. Securities and Exchange Commission (the “SEC”) on July 24, 2024 (File No. 333-280965), was declared effective on October 7, 2024 (as amended, the “IPO Registration Statement”). On October 9, 2024, the Company consummated the initial public offering of 23,000,000 units (collectively, the “Units”), which included the full exercise of the Over-Allotment Option (as defined in Note 6) in the amount of 3,000,000 units (the “Option Units”), at $10.00 per Unit, generating gross proceeds of $230,000,000 (the “Initial Public Offering”), which is described in Note 3. Each Unit consists of one Class A ordinary share, par value $0.0001 per share, of the Company (collectively, the “Class A Ordinary Shares” and with respect to the Class A Ordinary Shares included in the Units, the “Public Shares”) and one-half of one redeemable warrant of the Company (collectively, the “Public Warrants”).

 

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of an aggregate of 7,075,000 warrants (collectively, the “Private Placement Warrants,” and together with the Public Warrants, the “Warrants”) at a price of $1.00 per Private Placement Warrant, in a private placement to (i) the Company’s sponsor, Launch Two Sponsor LLC (the “Sponsor”), and (ii) Cantor Fitzgerald & Co. (“Cantor”), the representative of the several underwriters of the Initial Public Offering (collectively, the “Underwriters”), generating gross proceeds to the Company of $7,075,000 (the “Private Placement”), which is described in Note 4. Of the 7,075,000 Private Placement Warrants, the Sponsor purchased 4,500,000 Private Placement Warrants and Cantor purchased 2,575,000 Private Placement Warrants. Each whole Warrant entitles the holder to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment.

 

Additionally, at the closing of the Initial Public Offering on October 9, 2024, the Company paid the Underwriters the cash underwriting discount of 2.0% of the gross proceeds of the Units sold in the Initial Public Offering, excluding the Option Units, or $4,000,000 in the aggregate.

 

Transaction costs amounted to $15,615,485, consisting of $4,000,000 of cash underwriting discount, the Deferred Fee (as defined in Note 6) of $10,950,000 and $665,485 of other offering costs.

 

The Company’s management (“Management”) has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the Private Placement, although substantially all of the net proceeds are intended to be generally applied toward consummating a Business Combination (less the Deferred Fee).

 

The Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the net balance in the Trust Account (excluding the amount of the Deferred Fee held and taxes payable on the income earned on the Trust Account, if any) at the time of the signing an agreement to enter into a Business Combination. However, the Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully consummate a Business Combination.

 

5

 

 

LAUNCH TWO ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

Following the closing of the Initial Public Offering, on October 9, 2024, an amount of $231,150,000 ($10.05 per Unit) from the net proceeds of the Initial Public Offering and the Private Placement was placed in a trust account (the “Trust Account”), located in the United States, with Continental Stock Transfer & Trust Company (“Continental”) acting as trustee. The funds in the Trust Account may be invested only in U.S. Department of the Treasury (“Treasury”) obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act that invest only in direct Treasury obligations; the holding of these assets in this form is intended to be temporary and for the sole purpose of facilitating the intended Business Combination. To mitigate the risk that the Company might be deemed to be an investment company for purposes of the Investment Company Act, which risk increases the longer that the Company holds investments in the Trust Account, the Company may, at any time (based on Management’s ongoing assessment of all factors related to the Company’s potential status under the Investment Company Act), instruct the Continental to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest-bearing demand deposit account at a bank. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from the Initial Public Offering and the Private Placement will not be released from the Trust Account until the earliest of (i) the completion of the initial Business Combination, (ii) the redemption of the Public Shares if the Company is unable to complete the initial Business Combination by April 9, 2027 or by such earlier liquidation date as the Company’s board of directors (the “Board”) may approve (the “Combination Period”), subject to applicable law and as extended by the approval of the Extension Amendment Proposal (as defined in Note 10), or (iii) the redemption of the Public Shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (as currently in effect, the “Amended and Restated Articles”) to modify (1) the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company has not consummated an initial Business Combination within the Combination Period or (2) any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the holders of the Public Shares (the “Public Shareholders”).

 

The Company will provide the Public Shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of the initial Business Combination either (i) in connection with a general meeting called to approve the initial Business Combination or (ii) without a shareholder vote by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account (less taxes payable, if any), divided by the number of then outstanding Public Shares, subject to the limitations of applicable law and the Amended and Restated Articles. As of September 30, 2026, the amount in the Trust Account was $10.87 per Public Share.

 

The Class A Ordinary Shares subject to possible redemption were recorded at a redemption value and classified as temporary equity at the completion of the Initial Public Offering, in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”).

 

The Company has only the duration of the Combination Period to complete the initial Business Combination. If the Company is unable to complete its initial Business Combination within the Combination Period, the Company will cease all operations except for the purpose of winding up and as promptly as reasonably possible, but not more than ten business days after the end of the Combination Period, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (less taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will constitute full and complete payment for the Public Shares and completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation or other distributions, if any), subject to the Company’s obligations under Cayman Islands law to provide for claims of creditors and subject to the other requirements of applicable law.

 

The Sponsor and the Company’s officers and directors have entered into a letter agreement with the Company, dated October 7, 2024 (as amended, the “Letter Agreement”), pursuant to which they have agreed to (i) waive their redemption rights with respect to their Founder Shares (as defined in Note 5) and Public Shares in connection with (x) the completion of the initial Business Combination or an earlier redemption in connection with the commencement of the procedures to consummate the initial Business Combination if the Company determines it is desirable to facilitate the completion of the initial Business Combination and (y) a shareholder vote to approve an amendment to the Amended and Restated Articles to modify (1) the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company has not consummated an initial Business Combination within the Combination Period or (2) any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity; (ii) waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to complete the initial Business Combination within the Combination Period, although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the Combination Period and to liquidating distributions from assets outside the Trust Account; and (iii) vote any Founder Shares held by them and any Public Shares purchased during or after the Initial Public Offering (including in open market and privately negotiated transactions, aside from shares they may purchase in compliance with the requirements of Rule 14e-5 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which would not be voted in favor of approving the Business Combination) in favor of the initial Business Combination.

 

6

 

 

LAUNCH TWO ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.05 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.05 per Public Share due to reductions in the value of the Trust Account assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the Underwriters against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure its shareholders that the Sponsor will be able to satisfy those obligations.

 

NuCube Business Combination Agreement

 

On June 25, 2026, the Company entered into a Business Combination Agreement (as amended by the NuCube BCA First Amendment (as defined in Note 10), the “NuCube BCA”) with (i) NuCube Energy, Inc., a Delaware corporation (together with its successors, “NuCube”), (ii) Merger Sub, (iii) the Company’s Chief Executive Officer, Jay McEntee, in the capacity as the representative, from and after the Effective Time (as defined below), for the shareholders of the Company as of immediately prior to the Effective Time and their successors and assigns (other than the NuCube stockholders) (the “SPAC Representative”) and (iv) IdealabAZ, Inc., a Delaware corporation, in the capacity as representative, from and after the Effective Time, for the NuCube stockholders as of immediately prior to the Effective Time (the “Seller Representative”).

 

Pursuant to the NuCube BCA and subject to the terms and conditions set forth therein, (i) on or prior to the closing (the “Closing,” and the date and time of the Closing, the “Closing Date”) of the NuCube Business Combination, the Company will de-register from the Register of Companies of the Cayman Islands and transfer by way of continuation out of the Cayman Islands and into the State of Delaware so as to re-domicile as and become a Delaware corporation pursuant to Part 12 of the Companies Act (Revised) of the Cayman Islands and the applicable provisions of the General Corporation Law of the State of Delaware (the “Domestication”); and (ii) following the Domestication, (A) Merger Sub will merge with and into NuCube, with NuCube continuing as the surviving entity (the “Merger”) and, as a result of which, each share of NuCube common stock, par value $0.0001 per share (“NuCube Common Stock”) issued and outstanding immediately prior to the effective time of the Merger (the “Effective Time”) (after giving effect to the Preferred Conversion (as defined below)) shall no longer be outstanding and shall automatically be cancelled and cease to exist in exchange for the right to receive a number of shares of the Company’s common stock, par value $0.0001 per share (“SPAC Common Stock”) equal to the Exchange Ratio (as defined below), and (B) prior to the Effective Time, all outstanding shares of preferred stock of NuCube will either be exchanged for, or convert into, shares of NuCube Common Stock at the applicable conversion ratio (including any accrued or declared but unpaid dividends) in accordance with NuCube’s organizational documents (the “Preferred Conversion”). As a result of the Merger and the NuCube Business Combination, NuCube will become a wholly owned subsidiary of the Company, all upon the terms and subject to the conditions set forth in the NuCube BCA.

 

At the Effective Time, each outstanding option (whether vested or unvested) (each, a “NuCube Option”) to purchase NuCube Common Stock will be assumed by and automatically converted into an option for shares of SPAC Common Stock (each, an “Assumed Option”) subject to the same terms, conditions, vesting schedule and other provisions as are currently applicable to such NuCube Options; provided that each Assumed Option will be exercisable for the number of shares of SPAC Common Stock equal to the product of the Exchange Ratio (as defined below) multiplied by the number of shares of NuCube Common Stock subject to the NuCube Option as of immediately prior to the Effective Time, rounded down to the nearest whole number, at an exercise price equal to the quotient of the per share exercise price of the NuCube Option divided by the Exchange Ratio, rounded up to the nearest whole cent.

 

At the Effective Time, each warrant to purchase NuCube Common Stock (each, a “NuCube Warrant”) that is outstanding and unexercised immediately prior to the Effective Time shall be assumed by the Company and automatically converted into a warrant for shares of SPAC Common Stock (each, an “Assumed Warrant”). Each Assumed Warrant will be subject to the same terms, conditions and other provisions as are currently applicable to the applicable NuCube Warrant; provided that each Assumed Warrant will be exercisable for the number of shares of SPAC Common Stock equal to the product of the Exchange Ratio multiplied by the number of shares of NuCube Common Stock subject to such NuCube Warrant as of immediately prior to the Effective Time, rounded down to the nearest whole number, at an exercise price equal to the quotient of the per share exercise price of such NuCube Warrant divided by the Exchange Ratio, rounded up to the nearest whole cent.

 

7

 

 

LAUNCH TWO ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

Consideration

 

The aggregate consideration to be delivered to the security holders of NuCube as of the Effective Time will be a number of newly issued shares of SPAC Common Stock equal to the quotient of (A) $500,000,000 minus the excess of the Company’s expenses (if any) over $5,000,000 (such net amount, the “Purchase Price”), divided by (B) $10.82 (the “Reference Price”), with each holder of NuCube Common Stock (each, a “NuCube Stockholder”) receiving, for each share of NuCube Common Stock held immediately prior to the Effective Time (after giving effect to the Preferred Conversion or otherwise treating shares of NuCube Preferred Stock on an as-converted to NuCube Common Stock basis), a number of shares of SPAC Common Stock equal to the Exchange Ratio, each holder of NuCube Options receiving for such holder’s NuCube Options then held the Assumed Options, and each holder of NuCube Warrants receiving for such holder’s NuCube Warrants then held the Assumed Warrants. The Exchange Ratio refers to the quotient obtained by dividing (i) the quotient of the Purchase Price divided by the Reference Price by (ii) the Fully Diluted Company Shares (as defined below) (the “Exchange Ratio”).

 

The NuCube BCA also provides for an earnout of up to 12,575,000 additional shares of SPAC Common Stock (the “Earnout Shares”) to NuCube Stockholders following the Closing. The Earnout Shares will be released from escrow if, during the three-year period following the Closing, the volume weighted average price of SPAC Common Stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations and similar transactions after the Closing) for at least 20 trading days within any consecutive 30 trading day period (the “Triggering Event”), subject to adjustment as set forth in the NuCube BCA. If the Triggering Event is achieved, 50% of the Earnout Shares will be released 90 days following confirmation of such Triggering Event (the “Determination Date”), and the remaining 50% of the Earnout Shares will be released 180 days after the Determination Date. If the Triggering Event is not achieved during the Earnout Period, the Earnout Shares will be forfeited to the Company and cancelled.

 

The “Fully Diluted Company Shares” means, without duplication, (a) the total number of shares of NuCube Common Stock issued and outstanding as of immediately prior to the Effective Time (after giving effect to the Preferred Conversion), plus (b) the aggregate number of shares of NuCube Common Stock issuable upon, or pursuant to the conversion of NuCube SAFEs, plus (c) the aggregate number of shares of NuCube Common Stock issuable upon, or pursuant to, the exercise of NuCube Options that are issued and outstanding as of immediately prior to the Effective Time, treating such outstanding NuCube Options as having been exercised in full (calculated on a “cashless” (i.e., net exercise) basis), plus (d) the aggregate number of shares of NuCube Common Stock issuable upon, or pursuant to, the exercise of NuCube Warrants that are issued and outstanding as of immediately prior to the Effective Time, treating such NuCube Warrants as having been exercised in full (calculated on a “cashless” (i.e., net exercise) basis).

 

Representations and Warranties

 

The NuCube BCA contains representations and warranties that are reasonably customary for similar transactions that are made by the parties as of the date of the NuCube BCA, or other specified dates, solely for the benefit of certain of the parties to the NuCube BCA, and in certain cases are subject to specified exceptions and materiality, Material Adverse Effect (as defined below), knowledge and other qualifications contained in the NuCube BCA or in information provided pursuant to certain disclosure schedules to the NuCube BCA. 

 

The representations and warranties of the parties contained in the NuCube BCA terminate as of, and do not survive, the Closing, and there are no indemnification rights for another party’s breach. The covenants and agreements of the parties contained in the NuCube BCA do not survive the Closing, except those covenants and agreements to be performed after the Closing, which covenants and agreements will survive until fully performed. 

 

Covenants of the Parties

 

Each party to the NuCube BCA has agreed to use its commercially reasonable efforts, and to cooperate fully with one another, to consummate the NuCube Business Combination. The NuCube BCA also contains certain customary covenants by each of the parties that apply during the period between the signing of the NuCube BCA and the earlier of the Closing or the termination of the NuCube BCA (the “Interim Period”), including (i) the provision of access to the applicable party’s properties, books and personnel; (ii) the operation of the parties’ respective businesses in the ordinary course of business; (iii) the current and timely filing of the Company’s public filings; (iv) no insider trading; (v) notifications to the other parties of certain breaches, consent requirements and other matters; (vi) obtaining third-party and regulatory approvals; (vii) tax matters; (viii) further assurances; (ix) public announcements; (x) confidentiality; and (xi) other covenants. The NuCube BCA also contains certain customary post-Closing covenants, including, without limitation, in regard to (1) tax matters; (2) the maintenance of books and records; and (3) the indemnification of directors and officers.

 

Additionally, both the Company and NuCube agreed that it will not solicit or enter into a competing alternative transaction, in accordance with customary terms and provisions set forth in the NuCube BCA.

 

8

 

 

LAUNCH TWO ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

The Company agreed that it will not approve, endorse or recommend, or publicly propose to approve, endorse or recommend, any Acquisition Proposal, or otherwise change, withdraw, withhold, qualify or modify, or publicly propose to change, withdraw, withhold, qualify or modify its recommendation to its shareholders (the “SPAC Board Recommendation”) for approval of the NuCube BCA and the NuCube Business Combination (a “Change in Recommendation”); provided, however, that if the Company’s board of directors (the “SPAC Board”), after consultation with its outside legal counsel, determines in good faith, in response to an Intervening Event, that the failure to make a Change in Recommendation would be a breach of its fiduciary duties under applicable law, then the SPAC Board may make a Change in Recommendation; provided that SPAC will not be entitled to make a Change in Recommendation unless (i) the Company delivers to NuCube a written notice advising NuCube that the SPAC Board proposes to take such action and containing the material facts underlying its determination that an Intervening Event has occurred, and (ii) at or after 5:00 p.m., New York City time, on the fifth Business Day immediately following delivery of such notice (subject to an additional three Business Day period for any new notice relating to a material development with respect to such Intervening Event), the SPAC Board reaffirms in good faith, after consultation with its outside legal counsel and taking into account any adjustments to the terms of the NuCube BCA offered by NuCube, that the failure to make a Change in Recommendation would be a breach of its fiduciary duties under applicable law; provided that any Change in Recommendation shall not affect the Company’s obligations to call an extraordinary general meeting to approve the SPAC Shareholder Approval Matters.

 

NuCube will deliver to the Company financial statements of NuCube audited by a PCAOB-qualified auditor in accordance with PCAOB auditing standards, accompanied by an unqualified opinion of the auditor thereon (collectively, the “Audited Financials”), as soon as reasonably practicable after the date of the NuCube BCA but no later than 45 days from the date of the NuCube BCA (the “Audit Delivery Date”).

 

The Company and NuCube will, as promptly as practicable after the date of the NuCube BCA, prepare and file with the SEC, a registration statement on Form S-4 (as amended, the “NuCube Registration Statement”) in connection with the registration under the Securities Act, of the securities of the Company to be issued pursuant to the NuCube Business Combination, and containing a proxy statement/prospectus for the solicitation of proxies from the Company shareholders to approve the NuCube BCA, the NuCube Business Combination and related matters at an extraordinary general meeting of the Company’s shareholders (the “SPAC Special Meeting”), and providing the Company’s public shareholders with an opportunity to request redemption of their public shares in connection with the NuCube Business Combination, as required by the Amended and Restated Articles and the IPO Registration Statement (the “Redemption”).

 

As promptly as practicable after the NuCube Registration Statement has become effective and distributed by the Company (and in all cases within ten days following such date), NuCube will either (a) call a meeting of its stockholders to obtain and deliver to the Company a written consent of the NuCube Stockholders in order to approve the NuCube BCA and each of the ancillary documents to which NuCube is or is required to be a party or bound and the consummation of the transactions contemplated thereby (the “NuCube Stockholder Approval”) or (b) use its reasonable best efforts to obtain a signed written consent in lieu of a meeting of its stockholders for the NuCube Stockholder Approval. At the request of the Company, NuCube shall make the members of its management reasonably available to participate in management presentations, “road shows,” rating agency presentations, meetings with financing sources and similar events in connection with obtaining the approval of the Company shareholders, any “share recycling” efforts by the Company and the obtaining of any debt or equity financing (including Transaction Financings), ratings or governmental or other third-party approvals.

 

The parties shall take all action necessary so that, effective at the Closing, the post-Closing board of directors of the Company (the “Post-Closing Board”) will consist of at least seven individuals, two of whom will be designated by the Company (each of whom shall be independent directors in accordance with the requirements of Nasdaq), five of whom will be designated by NuCube (at least three of whom shall be independent directors in accordance with the requirements of Nasdaq). The amended and restated organizational documents of the Company will provide for a classified board structure consisting of three classes of directors serving staggered terms. In addition, at or prior to the Closing, the Company will enter into customary director indemnification agreements with each member of the Post-Closing Board. The parties shall also take all action necessary so that the individuals serving as the chief executive officer and chief financial officer, respectively, of the Company immediately after the Closing will be the same individuals (in the same office) as that of NuCube immediately prior to the Closing (unless, at its sole discretion, NuCube desires to appoint another qualified person to either such role, in which case, such other person(s) identified by NuCube shall serve in such role or roles).


During the Interim Period, the Company and NuCube shall use reasonable best efforts to enter into written agreements for Transaction Financings (as defined below) with aggregate proceeds of at least $100 million (on such terms and structuring and using such strategy, placement agents and approach, as the Company and NuCube shall mutually agree). “Transaction Financings” mean capital raising transactions in connection with the NuCube Business Combination structured as one or a combination of common equity, preferred equity, convertible equity or debt, non-redemption or backstop arrangements with respect to the Trust Account, a committed equity facility, debt facility, and/or other sources of cash or cash equivalents, in each case, whether such investment is into the Company or NuCube.

 

9

 

 

LAUNCH TWO ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

Conditions to Closing

 

The obligations of the parties to consummate the NuCube Business Combination are subject to various conditions, including the following mutual conditions of the parties, unless waived: (i) the approval of the NuCube BCA and the NuCube Business Combination and related matters by the requisite vote of each of the Company’s shareholders and NuCube’s stockholders; (ii) the expiration or termination of any waiting period applicable to the consummation of the NuCube BCA under any antitrust laws; (iii) obtaining applicable regulatory approvals; (iv) no law or order preventing or prohibiting the NuCube Business Combination; (v) appointment of the Post-Closing Board consistent with the requirements of the NuCube BCA; (vi) the effectiveness of the NuCube Registration Statement; (vii) the Amended Organizational Documents shall have been adopted as the Organizational Documents of the Company; (viii) the SPAC Common Stock shall have been approved for listing on Nasdaq or the New York Stock Exchange upon the Closing; and (ix) the Company having adopted, on or prior to the Closing, an incentive plan substantially in the form attached to the NuCube BCA.

 

In addition, unless waived by NuCube, the obligations of NuCube to consummate the NuCube Business Combination are subject to the satisfaction of the following closing conditions, in addition to customary certificates and other closing deliveries: (i) the representations of the Company relating to organization and standing, authorization, non-contravention, capitalization (other than certain portions of such representation in the NuCube BCA) and finders and brokers being true and correct in all material respects on and as of the date of the NuCube BCA and as of the Closing Date (except to the extent that any such representation and warranty is expressly made as of an earlier date, in which case such representation and warranty shall be true and correct in all material respects as of such earlier date); (ii) the representations and warranties of the Company set forth in certain portions of the capitalization representation being true and correct in all respects (except for de minimis inaccuracies) on and as of the date of the NuCube BCA and as of the Closing Date (except to the extent that any such representation and warranty is expressly made as of an earlier date, in which case such representation and warranty shall be true and correct in all respects (except for de minimis inaccuracies) as of such earlier date); (iii) all other representations and warranties of the Company being true and correct (without giving effect to any limitations as to “materiality” or any similar limitation set forth herein) in all respects on and as of the date of the NuCube BCA and as of the Closing Date, as though made on and as of the Closing Date (except to the extent that any such representation and warranty is expressly made as of an earlier date, in which case such representation and warranty shall be true and correct in all respects as of such earlier date), except where the failure of such representations and warranties to be true and correct, individually and in the aggregate has not had a Material Adverse Effect; (iv) the Company having performed in all material respects its obligations and complied in all material respects with the covenants and agreements under the NuCube BCA required to be performed or complied with by the Company on or prior to the Closing Date; (v) the sum of (x) the aggregate cash proceeds available for release from the Trust Account (after giving effect to the completion and payment of the Redemption), plus (y) the aggregate gross proceeds of any Transaction Financings minus (z) the aggregate amount of each party’s Expenses, shall equal or exceed $75,000,000; (vi) each of the Sponsor Support Agreement, the Insider Letter Amendment and the Amended Registration Rights Agreement shall be in full force and effect in accordance with the terms thereof as of the Closing; and (vii) the Company shall have delivered certain other documents as set forth in the NuCube BCA.

 

Unless waived by the Company, the obligations of the Company to consummate the NuCube Business Combination are subject to the satisfaction of the following closing conditions, in addition to customary certificates and other closing deliveries: (i) the representations of NuCube relating to capitalization being true and correct in all respects (except for de minimis inaccuracies) on and as of the date of the NuCube BCA and as of the Closing Date; (ii) the representations of NuCube relating to organization and standing, authorization, non-contravention, capitalization (other than the certain portions of such representation in the NuCube BCA) and finders and brokers being true and correct (without giving effect to any limitation as to “materiality” set forth therein) in all material respects on and as of the date of the NuCube BCA and as of the Closing Date (except to the extent that any such representation and warranty is expressly made as of an earlier date, in which case such representation and warranty shall be true and correct in all material respects as of such earlier date); (iii) all other representations and warranties of NuCube being true and correct (without giving effect to any limitation as to “materiality” or “Material Adverse Effect” or any similar limitation set forth herein) in all respects on and as of the date of the NuCube BCA and on and as of the Closing Date (except to the extent that any such representation and warranty is expressly made as of an earlier date, in which case such representation and warranty shall be true and correct in all respects as of such earlier date), except where the failure of such representations and warranties to be true and correct, individually and in the aggregate has not had a Material Adverse Effect on NuCube; (iv) NuCube having performed in all material respects all of its obligations and complied in all material respects with all of its agreements and covenants under the NuCube BCA required to be performed or complied with on or prior to the Closing Date; (v) absence of any Material Adverse Effect with respect to NuCube since the date of the NuCube BCA which is continuing and uncured; (vi) the Company Support Agreement, the Non-Competition Agreement, the Employment Agreement, and the Amended Registration Rights Agreement being in full force and effect as of the Closing; (vii) the Preferred Conversion shall have been completed; and (viii) NuCube having delivered certain other documents as set forth in the NuCube BCA.

 

Termination

 

The NuCube BCA was initially able to be terminated at any time prior to the Closing by either obtained the Company or NuCube if the Closing did not occur by October 9, 2026 (the “Outside Date”); provided that if the Company obtains, prior to the Outside Date, (i) agreements have been entered into for Transaction Financing in the aggregate gross amount of at least $75,000,000 and (ii) the approval of its shareholders for an extension of the Combination Period, then the Outside Date would be automatically be amended to November 9, 2026; provided further that this right to terminate the NuCube BCA would not be available to any party if the breach or violation by such party or its affiliates of any representation, warranty, covenant or obligation under the NuCube BCA was the cause of, or resulted in, the failure of the Closing to occur on or before the Outside Date. On October 19, 2026, the Outside Date was extended to January 7, 2027 (see Note 10).

10

 

 

LAUNCH TWO ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

The NuCube BCA may also be terminated under certain other customary and limited circumstances at any time prior to the Closing, including, among other reasons: (i) by mutual written consent of the Company and NuCube; (ii) by written notice by either the Company or NuCube to the other if a governmental authority of competent jurisdiction shall have issued an order or taken any other action permanently restraining, enjoining or otherwise prohibiting the NuCube Business Combination, and such order or other action has become final and non-appealable; (iii) by NuCube for the Company’s uncured breach of the NuCube BCA, such that the related closing condition would not be met; (iv) by the Company for NuCube’s uncured breach of the NuCube BCA, such that the related closing condition would not be met; (v) by the Company, if there shall have been a Material Adverse Effect on NuCube following the date of the NuCube BCA which is (or are) not cured and continuing; (vi) by NuCube prior to obtaining the approval of the Company’s shareholders, if the SPAC Board shall have (x) made a Change in Recommendation or (y) failed to include the SPAC Board Recommendation in the proxy statement; provided, however, that NuCube shall provide such written notice, if at all, within 72 hours after the occurrence of either (x) or (y) above; (vii) by either NuCube or the Company if the Company holds the SPAC Special Meeting to approve the NuCube BCA and the NuCube Business Combination, and such approval is not obtained; (viii) by either NuCube or the Company if NuCube’s meeting to approve the Company Stockholder Approval was held and NuCube’s stockholder approval was not obtained; and (ix) by written notice from the Company to NuCube, at any time within 60 days after the Audit Delivery Date, if NuCube has not delivered the Audited Financials prior to the date of such notice of termination.

 

If the NuCube BCA is terminated, all further obligations of the parties under the NuCube BCA (except for certain obligations related to public announcements, confidentiality, effect of termination, fees and expenses, trust account waiver, and customary miscellaneous provisions) will terminate, and no party to the NuCube BCA will have any further liability to any other party thereto except for liability for fraud or for willful breach of the NuCube BCA prior to such termination.

 

Liquidity, Capital Resources, and Going Concern

 

The Company’s liquidity needs through October 9, 2024 were satisfied through (i) a payment of $25,000 from the Sponsor in exchange for the issuance of the Founder Shares and (ii) a loan pursuant to the IPO Promissory Note (as defined in Note 5). Following the Initial Public Offering and the Private Placement, the Company’s liquidity needs through September 30, 2026 have been satisfied through (i) the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside the Trust Account and (ii) $750,000 of proceeds advanced by the Sponsor pursuant to the Working Capital Note (as defined in Note 5), which matures on the earliest of the consummation of the initial Business Combination, the Company’s winding up and February 17, 2027, subject to the Company’s election to extend the maturity (see Note 5).

 

As of September 30, 2026, the Company had operating cash of $222,351 and a working capital deficit of $1,874,756. The Company uses the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.

 

The Company has incurred and expects to continue to incur significant costs in pursuit of its acquisition plans. The Company may need to raise additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company Working Capital Loans (as defined in Note 5), from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. If the Company is unable to complete the Business Combination because it does not have sufficient funds available, the Company will be forced to cease operations and liquidate the Trust Account.

 

Management plans to address this uncertainty through the NuCube Business Combination. If a Business Combination is not consummated by the end of the Combination Period, currently April 9, 2027, there will be a mandatory liquidation and subsequent dissolution of the Company. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements - Going Concern,” Management has determined the Company’s liquidity condition, the February 17, 2027 maturity of the Working Capital Note (which precedes the end of the Combination Period), the date of mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might result from the Company’s inability to continue as a going concern.

 

NOTE 2. SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in the accompanying unaudited condensed consolidated financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of Management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

11

 

 

LAUNCH TWO ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the (i) IPO Registration Statement and (ii) Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as filed with the SEC on March 27, 2026. The interim results for the three and nine months ended September 30, 2026 and 2025, are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2026 or for any future periods.

 

Principles of Consolidation

 

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, Merger Sub, which was formed on May 18, 2026. All significant intercompany balances and transactions have been eliminated in consolidation.

 

Emerging Growth Company Status

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

  

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the accompanying unaudited condensed consolidated financial statements with another public company that is neither an (i) emerging growth company nor (ii) emerging growth company that has opted out of using the extended transition period, difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

 

The preparation of the accompanying unaudited condensed consolidated financial statements in conformity with GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the accompanying unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.

   

Making estimates requires Management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the accompanying unaudited condensed consolidated financial statements, which Management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $222,351 and $250,079 in cash and no cash equivalents as of September 30, 2026 and December 31, 2025, respectively.

  

Cash and Marketable Securities Held in Trust Account

 

The Company’s portfolio of investments is comprised of cash and Treasury securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in Treasury securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of Treasury securities, the investments are classified as trading securities, which are presented at fair value. Gains and losses resulting from the change in fair value of these securities are included in unrealized gain (loss) on cash and marketable securities held in Trust Account in the accompanying unaudited condensed consolidated statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. As of September 30, 2026 and December 31, 2025, the assets held in the Trust Account of $249,943,983 and $243,358,236, respectively, were held in cash and money market funds (see Note 8).

 

12

 

 

LAUNCH TWO ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

For the three and nine months ended September 30, 2026 and 2025, the Company recorded $2,261,800 and $6,585,747, $2,533,302 and $7,473,450, respectively, of interest earned on cash and marketable securities held in Trust Account in the accompanying unaudited condensed consolidated statements of operations. For the three and nine months ended September 30, 2026 and 2025, the Company did not withdraw any interest earned on the Trust Account.

 

Offering Costs

 

The Company complies with the requirements of FASB ASC Topic 340-10-S99, “Other Assets and Deferred Costs – SEC Materials,” and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering.” Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC Topic 470-20, “Debt with Conversion and Other Options,” addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Public Shares and Public Warrants, using the residual method by allocating Initial Public Offering proceeds first to assigned value of the Public Warrants and then to the Public Shares. Offering costs allocated to the Public Shares were charged to temporary equity. Offering costs allocated to the Warrants were charged to shareholders’ deficit as the Warrants were accounted for under equity treatment based on the equity classification of the underlying financial instruments, after Management’s evaluation.

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. 

  

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature.

 

Income Taxes

 

The Company accounts for income taxes under FASB ASC Topic 740, “Income Taxes” (“ASC 740”), which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the accompanying unaudited condensed consolidated financial statements and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. Management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2026 and December 31, 2025, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.

 

Warrant Instruments

 

The Company accounted for 11,500,000 Public Warrants and 7,075,000 Private Placement Warrants issued in connection with the Initial Public Offering and the Private Placement in accordance with the guidance contained in FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). Accordingly, the Company evaluated and recorded the warrant instruments under equity treatment at fair value. Such guidance provides that the Warrants described above were not precluded from equity classification. Equity-classified contracts are initially measured at fair value (or allocated value). Subsequent changes in fair value are not recognized as long as the contracts continue to be classified in equity in accordance with ASC 480 and ASC 815.

 

13

 

 

LAUNCH TWO ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

Class A Ordinary Shares Subject to Possible Redemption

 

The Public Shares contain a redemption feature that allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the initial Business Combination. In accordance with FASB ASC Topic 480-10-S99, “Distinguishing Liabilities from Equity,” the Company classifies Public Shares subject to possible redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable Public Shares to equal the redemption value at the end of each reporting period. At closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable Class A Ordinary Shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of September 30, 2026 and December 31, 2025, Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the accompanying condensed consolidated balance sheets. As of September 30, 2026 and December 31, 2025, Class A Ordinary Shares subject to possible redemption reflected in the condensed consolidated balance sheets are reconciled in the following table:

 

Class A Ordinary Shares subject to possible redemption, December 31, 2024   $ 233,538,339  
Plus:        
Accretion of carrying value to redemption value     9,819,897  
Class A Ordinary Shares subject to possible redemption, December 31, 2025     243,358,236  
Plus:        
Accretion of carrying value to redemption value     2,149,376  
Class A Ordinary Shares subject to possible redemption, March 31, 2026     245,507,612  
Plus:        
Accretion of carrying value to redemption value     2,174,571  
Class A Ordinary Shares subject to possible redemption, June 30, 2026     247,682,183  
Plus:        
Accretion of carrying value to redemption value     2,261,800  
Class A Ordinary Shares subject to possible redemption, September 30, 2026   $ 249,943,983  

 

Net Income per Ordinary Share

 

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company’s share capital consists of the Class A Ordinary Shares and the Company’s Class B ordinary shares, par value $0.0001 per share (the “Class B Ordinary Shares,” and together with the Class A Ordinary Shares, the “Ordinary Shares”). For purposes of computing net income per Ordinary Share, the Company has two classes of shares: (i) redeemable Class A Ordinary Shares, which are the Public Shares, and (ii) non-redeemable Class A Ordinary Shares and Class B Ordinary Shares. The 5,749,999 Class A Ordinary Shares issued to the Sponsor upon the conversion of an equal number of Class B Ordinary Shares on September 30, 2026 are not redeemable and, accordingly, are included in the non-redeemable class together with the Class B Ordinary Shares for all periods. Income and losses are shared pro rata between the two classes of shares. Net income per Ordinary Share is computed by dividing net income by the weighted average number of Ordinary Shares outstanding during the period, excluding Ordinary Shares subject to forfeiture. The Company has not considered the effect of the 18,575,000 Warrants (11,500,000 Public Warrants and 7,075,000 Private Placement Warrants) sold in the Initial Public Offering and the Private Placement to purchase an aggregate of 18,575,000 Class A Ordinary Shares in the calculation of diluted net income per Ordinary Share, because their exercise is contingent upon the occurrence of future events (the Warrants cannot be exercised until 30 days after the completion of the initial Business Combination; see Note 7). As a result, diluted net income per Ordinary Share is the same as basic net income per Ordinary Share for the periods presented.

 

The tables below present a reconciliation of the numerator used to compute basic and diluted net income per Ordinary Share.

 

    For the Three Months Ended
September 30,
    For the Nine Months Ended
September 30,
 
    2026     2025     2026     2025  
    Redeemable
shares
    Non-
redeemable
shares
    Redeemable
shares
    Non-
redeemable
shares
    Redeemable
shares
    Non-
redeemable
shares
    Redeemable
shares
    Non-
redeemable
shares
 
Basic and diluted net income per Ordinary Share:                                                
Numerator:                                                
Allocation of net income   $ 1,112,019     $ 278,005     $ 1,815,132     $ 453,783     $ 3,606,126     $ 901,532     $ 5,481,424     $ 1,370,356  
Denominator:                                                                
Basic weighted average Ordinary Shares outstanding     23,000,000       5,750,000       23,000,000       5,750,000       23,000,000       5,750,000       23,000,000       5,750,000  
Basic and diluted net income per Ordinary Share   $ 0.05     $ 0.05     $ 0.08     $ 0.08     $ 0.16     $ 0.16     $ 0.24     $ 0.24  

14

 

 

LAUNCH TWO ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

Recent Accounting Standards

 

In November 2024, the FASB issued Accounting Standards Update (“ASU”) Topic 2024-03, “Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses” (“ASU 2024-03”), requiring public entities to disclose additional information about specific expense categories in the notes to the unaudited condensed consolidated financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03. 

 

Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the accompanying unaudited condensed consolidated financial statements.

 

NOTE 3. INITIAL PUBLIC OFFERING

  

In the Initial Public Offering, on October 9, 2024, the Company sold 23,000,000 Units, which included the full exercise of the Over-Allotment Option in the amount of 3,000,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one Public Share, and one-half of one Public Warrant. Each whole Public Warrant entitles the holder to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment (see Note 7).

 

NOTE 4. PRIVATE PLACEMENT

 

Simultaneously with the closing of the Initial Public Offering, the Sponsor and Cantor purchased an aggregate of 7,075,000 Private Placement Warrants, each exercisable to purchase one Class A Ordinary Share at $11.50 per share, at a price of $1.00 per Private Placement Warrant, or $7,075,000 in the aggregate. Of those 7,075,000 Private Placement Warrants, the Sponsor purchased 4,500,000 Private Placement Warrants and Cantor purchased 2,575,000 Private Placement Warrants. Each whole Private Placement Warrant entitles the registered holder to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment (see Note 7).

 

The Private Placement Warrants are identical to the Public Warrants sold in the Initial Public Offering except that, so long as they are held by the Sponsor, Cantor, or their permitted transferees, the Private Placement Warrants (i) may not (including the Class A Ordinary Shares issuable upon exercise of these Private Placement Warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business Combination, (ii) are entitled to registration rights and (iii) with respect to the Private Placement Warrants held by Cantor and/or its designees, will not be exercisable more than five years from the commencement of sales in the Initial Public Offering in accordance with Financial Industry Regulatory Authority Rule 5110(g)(8).

 

NOTE 5. RELATED PARTY TRANSACTIONS

 

Founder Shares

 

On May 13, 2024, the Sponsor made a payment of $25,000, or approximately $0.004 per share, to cover certain of the Company’s expenses, for which the Company issued 5,750,000 Class B Ordinary Shares, to the Sponsor (such shares, the “Founder Shares”). Up to 750,000 of the Founder Shares were subject to forfeiture by the Sponsor for no consideration depending on the extent to which the Over-Allotment Option was exercised. On October 9, 2024, the Underwriters exercised their Over-Allotment Option in full as part of the closing of the Initial Public Offering. As such, the 750,000 Founder Shares are no longer subject to forfeiture.

 

The holders of the Founder Shares have agreed not to transfer, assign or sell any of their Founder Shares and any Class A Ordinary Shares issued upon conversion thereof until the earlier to occur of (i) one year after the completion of the initial Business Combination or (ii) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction after the initial Business Combination that results in all of the Company’s shareholders having the right to exchange their Class A Ordinary Shares for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements of such initial holders of the Founder Shares with respect to any Founder Shares (the “Lock-up”). Notwithstanding the foregoing, if (1) the closing price of the Class A Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination or (2) if the Company consummates a transaction after the initial Business Combination that results in the Company’s shareholders having the right to exchange their Ordinary Shares for cash, securities or other property, the Founder Shares will be released from the Lock-up (see Note 1 for more information on the Founder Share in connection with the NuCube Business Combination.)

  

15

 

 

LAUNCH TWO ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

IPO Promissory Note

 

The Sponsor agreed to loan the Company an aggregate of up to $300,000 to be used for a portion of the expenses of the Initial Public Offering pursuant to a promissory note (the “IPO Promissory Note”). The loan was non-interest bearing, unsecured and due at the earlier of December 31, 2024 or the closing of the Initial Public Offering. As of September 30, 2026 and December 31, 2025, the Company had borrowed $0 under the IPO Promissory Note. The Company repaid all the outstanding balance of the IPO Promissory Note at the closing of the Initial Public Offering on October 9, 2024 and borrowings under the IPO Promissory Note are no longer available. 

 

Advance from Related Party

 

Prior to the Initial Public Offering, the Company received a $42,923 advance from the Sponsor. The Company repaid the advance in full upon the closing of the Initial Public Offering. As of September 30, 2026 and December 31, 2025, there were no amounts outstanding.

 

Administrative Services Agreement

 

The Company entered into agreements with an affiliate of the Sponsor pursuant to which, commencing on October 7, 2024, through the earlier of consummation of the initial Business Combination or the liquidation, the Company pays an aggregate of $12,500 per month for office space, utilities, and secretarial and administrative support. For the three and nine months ended September 30, 2026, the Company incurred $37,500 and $112,500, respectively, in fees for these services, which amounts are included in general and administrative costs in the accompanying unaudited condensed consolidated statements of operations. As of September 30, 2026, $112,500 of such fees had not been paid and is included in accrued expenses in the accompanying condensed consolidated balance sheets. For the three and nine months ended September 30, 2025, the Company incurred and paid $37,500 and $112,500, respectively, in fees for these services, which amounts are included in general and administrative costs in the accompanying unaudited condensed consolidated statements of operations.

 

Working Capital Loans

 

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes a Business Combination, the Company intends to repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans, but no proceeds from the Trust Account will be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants. As of September 30, 2026 and December 31, 2025, no such Working Capital Loans were outstanding.

 

Working Capital Promissory Note

 

On August 17, 2026, the Company issued a promissory note to the Sponsor in the principal amount of $848,000 (the “Working Capital Note”). Of the principal, $750,000 was cash advanced to the Company on August 7, 2026, $48,000 was retained by the Sponsor as an interest reserve, and $50,000 was withheld to reimburse the lender’s fees and expenses. The Working Capital Note bears interest at 8.00% per annum, payable monthly in arrears, with an additional 18.00% upon default. It matures on the earliest of the consummation of the Business Combination, the Company’s winding up, or February 17, 2027 (the six-month anniversary of issuance). At the Company’s election, maturity may be extended for two months and then three months, for fees of 1.0% and 1.5% of principal, respectively, added to principal. Prepayment requires the Sponsor’s consent and a 10% premium. The Company carries the Working Capital Note at amortized cost; the $98,000 difference between the principal amount and the $750,000 of cash proceeds (consisting of the $48,000 interest reserve and the $50,000 reimbursement of the lender’s fees and expenses) was recorded as a debt discount, which is being amortized to interest expense on a straight-line basis (which is not materially different from the effective interest method) through February 17, 2027, the maturity date of the Working Capital Note. Because the $48,000 interest reserve retained by the Sponsor funds the stated interest for the first six months of the term, no separate interest is accrued for that period. As of September 30, 2026, the net carrying amount was $773,435, consisting of principal of $848,000, less unamortized discount of $74,565. Interest expense, consisting of amortization of the debt discount, for the three and nine months ended September 30, 2026 was $23,435.

 

Credit, Pledge and Consulting Agreements

 

In connection with the Working Capital Note, the Sponsor entered into a credit agreement (the “Credit Agreement”) with a lender (the “Lender”) for a loan of $848,000. To secure its obligations, the Sponsor pledged 2,932,500 Founder Shares (which were converted into Class A Ordinary Shares on September 30, 2026), representing approximately 51% of the Founder Shares owned by the Sponsor, together with any proceeds thereof (the “Pledged Collateral”), pursuant to a pledge agreement (the “Pledge Agreement”). Upon consummation of the Company’s initial Business Combination, the Sponsor is required to transfer 150,000 Founder Shares to the Lender as partial consideration for the loan (the “Consideration Shares”), which are included in the Pledged Collateral. The loan is non-recourse to the Sponsor, and the Lender’s sole recourse upon default is the Pledged Collateral, subject to the Company’s governing documents and applicable transfer restrictions, including the Letter Agreement.

 

16

 

 

LAUNCH TWO ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

The Sponsor is required to use the loan proceeds to fund loans to the Company for expenses, including Business Combination transaction costs, amounts owed for prior Business Combination efforts and administrative expenses. The loan matures upon the earliest of the Company’s initial Business Combination, liquidation or the six-month anniversary of the Credit Agreement, subject to extension by the Company. Events of default include the Company’s failure to file a proxy statement to extend the Combination Period or enter into a definitive Business Combination agreement by specified dates. The Credit Agreement and Pledge Agreement bind only the Sponsor and the Lender and do not restrict the actions of the Company.

 

On August 17, 2026, the Sponsor entered into a Consulting Services and Share Purchase Agreement (the “Consulting Agreement”) with Strategic Capital Advisories (“SCA”), pursuant to which SCA agreed to provide consulting services in connection with the Company’s initial Business Combination. As consideration, the Sponsor agreed to transfer 350,000 Founder Shares to SCA at $0.04 per share upon consummation of the Business Combination (the “Consulting Shares”), which are included in the Pledged Collateral.

 

In connection with these arrangements, the Company entered into a waiver letter with the Sponsor, Cantor, as representative of the Underwriters, and NuCube, which permits the pledge of the Pledged Collateral and the transfers of the Consideration Shares and Consulting Shares, in each case subject to the terms of the Letter Agreement.

   

NOTE 6. COMMITMENTS AND CONTINGENCIES

 

Risks and Uncertainties

 

The Company’s ability to complete an initial Business Combination may be adversely affected by various factors, many of which are beyond the Company’s control. The Company’s ability to consummate an initial Business Combination could be impacted by, among other things, changes in laws or regulations, downturns in the financial markets or in economic conditions, inflation, fluctuations in interest rates, increases in tariffs, supply chain disruptions, declines in consumer confidence and spending, public health considerations, and geopolitical instability, such as the military conflicts in Ukraine, between the United States, Israel and Iran and others in the Middle East, and Southwest Asia or other armed hostilities. The Company cannot at this time predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact the Company’s ability to complete an initial Business Combination.

 

Registration Rights Agreement

 

The holders of the Founder Shares, Private Placement Warrants and the Class A Ordinary Shares issuable upon exercise of such Private Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans are entitled to registration rights to require the Company to register a sale of any of the Company’s securities held by them and any other securities of the Company acquired by them prior to the consummation of the initial Business Combination pursuant to a registration rights agreement, dated October 7, 2024. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain piggyback registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. In addition, Cantor may participate in a piggyback registration only during the seven-year period beginning on the effective date of the IPO Registration Statement. Notwithstanding the foregoing, Cantor may not exercise its demand registration rights after five (5) years from the commencement of sales in the Initial Public Offering, and may not exercise its demand rights on more than one occasion.

 

Underwriting Agreement

 

The Underwriters had a 45-day option from the date of the Initial Public Offering to purchase up to an additional 3,000,000 Option Units to cover over-allotments, if any (the “Over-Allotment Option”). On October 9, 2024, simultaneously with the closing of the Initial Public Offering, the Underwriters elected to fully exercise the Over-Allotment Option to purchase the additional 3,000,000 Option Units at a price of $10.00 per Option Unit.

 

The Underwriters were entitled to a cash underwriting discount of $4,000,000 (2.0% of the gross proceeds of the Units, excluding any proceeds pursuant to the Over-Allotment Option), which was paid at the closing of the Initial Public Offering. Additionally, the Underwriters are entitled to a deferred underwriting fee of 4.50% of the gross proceeds of the Initial Public Offering, other than those sold pursuant to the Over-Allotment Option, and 6.50% of the gross proceeds sold pursuant to the Over-Allotment Option, $10,950,000 in the aggregate payable upon the completion of the initial Business Combination subject to the terms of the Underwriting Agreement, dated October 7, 2024, by and between the Company and Cantor (such fee, the “Deferred Fee”).

 

NuCube Business Combination Agreement

 

On June 25, 2026, the Company entered into the NuCube BCA with NuCube, Merger Sub, the SPAC Representative and the Seller Representative. See Note 1 for a description of the material terms of the NuCube BCA.

 

17

 

 

LAUNCH TWO ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

NOTE 7. SHAREHOLDERS’ DEFICIT

 

Preference Shares

 

The Company is authorized to issue a total of 5,000,000 preference shares at par value of $0.0001 each. As of September 30, 2026 and December 31, 2025, there were no preference shares issued or outstanding.

 

Class A Ordinary Shares

 

The Company is authorized to issue a total of 500,000,000 Class A Ordinary Shares at par value of $0.0001 each. As of September 30, 2026 and December 31, 2025, there were 5,749,999 and no Class A Ordinary Shares issued or outstanding, excluding 23,000,000 and 23,000,000 Class A Ordinary Shares subject to possible redemption, respectively.

 

Class B Ordinary Shares

 

The Company is authorized to issue a total of 50,000,000 Class B Ordinary Shares at par value of $0.0001 each. As of September 30, 2026 and December 31, 2025, there were one and 5,750,000 Class B Ordinary Shares issued and outstanding, respectively. On September 30, 2026, the Company issued an aggregate of 5,749,999 Class A Ordinary Shares to the Sponsor upon the conversion of an equal number of Class B Ordinary Shares.

 

The Founder Shares will automatically convert into Class A Ordinary Shares concurrently with or immediately following the consummation of the initial Business Combination or earlier at the option of the holder on a one-for-one basis, subject to adjustment for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A Ordinary Shares, or any other equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Initial Public Offering and related to or in connection with the closing of the initial Business Combination, the ratio at which Class B Ordinary Shares convert into Class A Ordinary Shares will be adjusted (unless the holders of a majority of the outstanding Class B Ordinary Shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A Ordinary Shares issuable upon conversion of all Class B Ordinary Shares will equal, in the aggregate, 20% of the sum of (i) the total number of all Class A Ordinary Shares outstanding upon the completion of the Initial Public Offering (including any Class A Ordinary Shares issued pursuant to the Over-Allotment Option and excluding the Class A Ordinary Shares issuable upon exercise of the Private Placement Warrants issued to the Sponsor), plus (ii) all Class A Ordinary Shares and equity-linked securities issued or deemed issued, in connection with the closing of the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination and any Private Placement-equivalent warrants issued to the Sponsor or any of its affiliates or to the Company’s officers or directors upon conversion of Working Capital Loans) minus (iii) any redemptions of Class A Ordinary Shares by Public Shareholders in connection with an initial Business Combination; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.

 

Holders of the Ordinary Shares are entitled to one vote for each Ordinary Share held on all matters to be voted on by shareholders. Unless specified in the Amended and Restated Articles or as required by the Companies Act (As Revised) of the Cayman Islands or stock exchange rules, an ordinary resolution under Cayman Islands law and the Amended and Restated Articles, which requires the affirmative vote of at least a majority of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the Company is generally required to approve any matter voted on by the Company’s shareholders. Approval of certain actions requires a special resolution under Cayman Islands law, which (except as specified below) requires the affirmative vote of at least two-thirds of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting, and pursuant to the Amended and Restated Articles, such actions include amending the Amended and Restated Articles and approving a statutory merger or consolidation with another company. There is no cumulative voting with respect to the appointment of directors, meaning, following the initial Business Combination, the holders of more than 50% of the Ordinary Shares voted for the appointment of directors can elect all of the directors. Prior to the consummation of the initial Business Combination, only holders of the Class B Ordinary Shares have the right to vote on (i) the appointment and removal of directors and (ii) continuing the Company in a jurisdiction outside the Cayman Islands (including any special resolution required to amend the constitutional documents or to adopt new constitutional documents, in each case, as a result of approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands). Holders of Class A Ordinary Shares are not entitled to vote on these matters during such time. These provisions of the Amended and Restated Articles may only be amended if approved by a special resolution passed by the affirmative vote of at least 90% (or, where such amendment is proposed in respect of the consummation of the initial Business Combination, two-thirds) of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the Company.

 

Warrants

 

As of September 30, 2026 and December 31, 2025, there were 18,575,000 Warrants outstanding, including 11,500,000 Public Warrants and 7,075,000 Private Placement Warrants. Each whole Warrant entitles the holder to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment as discussed herein. The Warrants cannot be exercised until 30 days after the completion of the initial Business Combination, and will expire at 5:00 p.m., New York City time, five years after the completion of the initial Business Combination or earlier upon redemption or liquidation.

 

18

 

 

LAUNCH TWO ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

The Company will not be obligated to deliver any Class A Ordinary Shares pursuant to the exercise of a Warrant and will have no obligation to settle such Warrant exercise unless a registration statement under the Securities Act with respect to the Class A Ordinary Shares issuable upon exercise of the Warrants is then effective and a prospectus relating thereto is current. No Warrant will be exercisable and the Company will not be obligated to issue a Class A Ordinary Share upon exercise of a Warrant unless the Class A Ordinary Share issuable upon such Warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the Warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a Warrant, the holder of such Warrant will not be entitled to exercise such Warrant and such Warrant may have no value and expire worthless. In no event will the Company be required to net cash settle any Warrant. In the event that a registration statement is not effective for the exercised Warrants, the purchaser of a unit containing such Warrant will have paid the full purchase price for the unit solely for the Class A Ordinary Share underlying such unit.

 

Under the terms of the Warrant Agreement, dated October 7, 2024, by and between the Company and Continental (the “Warrant Agreement”), the Company has agreed that, as soon as practicable, but in no event later than 20 business days after the closing of its Business Combination, it will use commercially reasonable efforts to file with the SEC a post-effective amendment to the IPO Registration Statement or a new registration statement covering the registration under the Securities Act of the Class A Ordinary Shares issuable upon exercise of the Warrants and thereafter will use its commercially reasonable efforts to cause the same to become effective within 60 business days following the Business Combination and to maintain a current prospectus relating to the Class A Ordinary Shares issuable upon exercise of the Warrants until the expiration of the Warrants in accordance with the provisions of the Warrant Agreement. If a registration statement covering the Class A Ordinary Shares issuable upon exercise of the Warrants is not effective by the sixtieth (60th) business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A Ordinary Shares are at the time of any exercise of a Warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Public Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, the Company will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

 

If the holders exercise their Public Warrants on a cashless basis, they would pay the warrant exercise price by surrendering the Public Warrants for that number of Class A Ordinary Shares equal to the quotient obtained by dividing (x) the product of the number of Class A Ordinary Shares issuable upon exercise of the Warrants, multiplied by the excess of the “fair market value” of the Class A Ordinary Shares over the exercise price of the Public Warrants by (y) the fair market value. The “fair market value” is the average reported closing price of the Class A Ordinary Shares for the 10 trading days ending on the third trading day prior to the date on which the notice of exercise is received by the warrant agent or on which the notice of redemption is sent to the holders of Public Warrants, as applicable.

  

Once the Warrants become exercisable, the Company may redeem the Public Warrants:

 

● in whole and not in part;

 

● at a price of $0.01 per Warrant;

 

● upon a minimum of 30 days’ prior written notice of redemption; and

 

● if, and only if, the closing price of the Class A Ordinary Shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of Class A Ordinary Shares issuable upon exercise or the exercise price of a Warrant) for any 20 trading days within a 30-trading day period commencing at least 30 days after completion of the Business Combination and ending three business days before the Company sends the notice of redemption to the warrant holders.

 

Additionally, if the number of outstanding Class A Ordinary Shares is increased by a share capitalization payable in Class A Ordinary Shares, or by a subdivision of Ordinary Shares or other similar event, then, on the effective date of such share capitalization, subdivision or similar event, the number of Class A Ordinary Shares issuable upon exercise of each Warrant will be increased in proportion to such increase in the outstanding Ordinary Shares. A rights offering made to all or substantially all holders of Ordinary Shares entitling holders to purchase Class A Ordinary Shares at a price less than the fair market value will be deemed a share capitalization of a number of Class A Ordinary Shares equal to the product of (i) the number of Class A Ordinary Shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for Class A Ordinary Shares) and (ii) the quotient of (x) the price per Class A Ordinary Share paid in such rights offering and (y) the fair market value. For these purposes (i) if the rights offering is for securities convertible into or exercisable for Class A Ordinary Shares, in determining the price payable for Class A Ordinary Shares, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) fair market value means the volume weighted average price of Class A Ordinary Shares as reported during the ten (10) trading day period ending on the trading day prior to the first date on which the Class A Ordinary Shares trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.

 

19

 

 

LAUNCH TWO ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

NOTE 8. FAIR VALUE MEASUREMENTS

 

The fair value of the Company’s financial assets and liabilities reflects Management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

 

Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
   
Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
   
Level 3: Unobservable inputs based on assessment of the assumptions that market participants would use in pricing the asset or liability.

 

Level 1 assets include investments in money market funds that invest solely in Treasury securities.

 

As of September 30, 2026, cash and marketable securities held in the Trust Account were comprised of $858 in cash and $249,943,125 in a money market fund, which was invested primarily in Treasury bills. At December 31, 2025, assets held in the Trust Account were comprised of $858 in cash and $243,357,378 in a money market fund, which was invested primarily in Treasury bills. For the three and nine months ended September 30, 2026, the Company did not withdraw any interest income from the Trust Account.

 

NOTE 9. SEGMENT INFORMATION

 

FASB ASC Topic 280, “Segment Reporting,” establishes standards for companies to report in their unaudited condensed consolidated financial statements information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the company’s chief operating decision maker (“CODM”), or group, in deciding how to allocate resources and assess performance.

 

The Company’s CODM has been identified as the Chief Financial Officer, who reviews the assets, operating results, and financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, Management has determined that there is only one reportable segment.

 

The CODM assesses performance for the single segment and decides how to allocate resources based on net income that also is reported on the accompanying unaudited condensed consolidated statements of operations as net income. The measure of segment assets is reported on the accompanying condensed consolidated balance sheets as total assets. When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net income and total assets, which include the following:

 

    September 30,
2026
    December 31,
2025
 
Cash and marketable securities held in Trust Account   $ 249,943,983     $ 243,358,236  
Cash   $ 222,351     $ 250,079  

 

    For the Three Months Ended
September 30,
    For the Nine Months Ended
September 30,
 
    2026     2025     2026     2025  
General and administrative costs   $ 848,355     $ 238,860     $ 2,054,687     $ 622,233  
Interest earned on cash and marketable securities held in Trust Account   $ 2,261,800     $ 2,533,302     $ 6,585,747     $ 7,473,450  

  

20

 

 

LAUNCH TWO ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

The CODM reviews interest earned on the Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the Investment Management Trust Agreement, dated October 7, 2024, by and between the Company and Continental.

 

General and administrative costs are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a Business Combination within the Combination Period. The CODM also reviews general and administrative costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. The accounting policies used to measure the profit and loss of the segment are the same as those described in the summary of significant accounting policies. General and administrative costs, as reported on the accompanying unaudited condensed consolidated statements of operations, are the significant segment expenses provided to the CODM on a regular basis.

 

All other segment items included in net income are reported on the accompanying unaudited condensed consolidated statements of operations and described within their respective disclosures.

 

NOTE 10. SUBSEQUENT EVENTS

 

The Company evaluated subsequent events and transactions that occurred after the accompanying condensed consolidated balance sheet date up to the date that the accompanying unaudited condensed consolidated financial statements were issued. Based upon this review, other than described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the accompanying unaudited condensed consolidated financial statements.

 

On October 8, 2026, the Company held an extraordinary general meeting in lieu of an annual general meeting of shareholders (the “EGM”). The Company’s shareholders approved, among other things, an amendment to the Amended and Restated Articles (the “Extension Amendment Proposal”) to extend the end of the Combination Period on a monthly basis, up to six (6) times, from October 9, 2026 to April 9, 2027, or such earlier date as determined by the Board. In connection with the vote to approve the Extension Amendment Proposal, Public Shareholders holding 18,322,071 Public Shares (after giving effect to withdrawals of redemptions) exercised their right to redeem such Public Shares for cash at a redemption price of approximately $10.84 per Public Share, for an aggregate redemption amount of approximately $198.6 million (the “EGM Redemptions”). Following the EGM Redemptions, there are 4,677,929 Public Shares currently issued and outstanding.

 

In connection with the EGM, the Company entered into agreements (collectively, the “Non-Redemption Agreements”) with a number of shareholders of the Company (each, an “Investor”) in exchange for such Investors agreeing (i) not to redeem (or to validly rescind any redemption requests previously made in respect of), and (ii) to vote or consent (in person or by proxy) in favor of the Extension Amendment Proposal, with respect to an aggregate of 4,481,851 Class A Ordinary Shares (such shares subject to the Non-Redemption Agreements, the “Non-Redeemed Shares”) at the EGM. In exchange for the foregoing commitments, the Sponsor agreed to transfer to such Investors an aggregate of 256,061 Class A Ordinary Shares held by the Sponsor per month, for each month of the extension of the Combination Period from October 9, 2026 until April 9, 2027, as needed, with such Class A Ordinary Shares to be transferred upon the closing of the initial Business Combination. Such transfer was conditional on, among other matters, (i) such Investors not exercising (or having validly rescinded any prior exercise of) their redemption rights with respect to the Non-Redeemed Shares in connection with the EGM, (ii) such shareholders voting or consenting in favor of the Extension Amendment Proposal at the EGM and (iii) the Extension Amendment Proposal being approved at the EGM. Each Non-Redemption Agreement shall terminate on the earliest of (i) the failure of the Investors to approve the Extension Amendment Proposal at the EGM, (ii) the fulfillment of all obligations of the parties under the Non-Redemption Agreement, (iii) the liquidation or dissolution of our Company, (iv) the mutual written agreement of the parties to the Non-Redemption Agreement, and (v) the exercise by a shareholder of its redemption rights with respect to the Non-Redeemed Shares or the failure by such Investor to vote in favor of the Extension Amendment Proposal at the EGM.

 

On October 19, 2026, the Company entered into Amendment No. 1 to the Business Combination Agreement with (a) NuCube, (b) Merger Sub (c) the SPAC Representative and (d) the Seller Representative (the “NuCube BCA First Amendment”) to (i) amend Section 7.1(b) of the NuCube BCA to extend the Outside Date (as defined in the NuCube BCA) to January 7, 2027, at 5:00 p.m., Eastern time, subject to the limitations on termination set forth therein, (ii) permit NuCube to enter into securities purchase agreements with investors from time to time prior to the Closing for the issuance and sale of a new series of its preferred stock designated as “Series A-4 Preferred Stock” (such investments, collectively, the “NuCube Financings”), on terms substantially similar to, and not materially more favorable to investors in the aggregate than, the financing terms set forth in Appendix A to the NuCube BCA First Amendment, (iii) amend the definition of Fully Diluted Company Shares (as defined in the NuCube BCA) with the result that the issuance of the Series A-4 Preferred Stock will not reduce the aggregate Merger Consideration (as defined in the NuCube BCA) to be received by holders of NuCube securities before giving effect to such issuance, (iv) increase the share reserve under the Incentive Plan (as defined in the NuCube BCA) from 10% to 12.5% of the Company’s outstanding shares after giving effect to the Closing, and (v) require the Company to establish a new employee stock purchase plan with a share reserve equal to 2% of the fully diluted equity capitalization after giving effect to the Closing. Such financing terms provide for the issuance of Series A-4 Preferred Stock at a purchase price of $12.779 per share, with a 1:1 conversion ratio and 50% warrant coverage at an exercise price of $15.887 per warrant share. The NuCube BCA First Amendment further confirms that the NuCube Financings shall constitute Transaction Financings (as defined in the NuCube BCA) for all purposes under the NuCube BCA. Other than as expressly modified pursuant to the NuCube BCA First Amendment, the NuCube BCA remains in full force and effect as originally executed.

 

21

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

  

Cautionary Note Regarding Forward-Looking Statements

 

All statements other than statements of historical fact included in this Report including, without limitation, statements under this Item regarding our financial position, possible Business Combinations and the financing thereof, and related matters, and the plans and objectives of Management for future operations, are forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. When used in this Report, words such as “may,” “should,” “could,” “would,” “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to us or our Management, identify forward-looking statements. We have based these forward-looking statements on our Management’s current expectations and projections about future events, as well as assumptions made by, and information currently available to, our Management. Actual results could differ materially from those contemplated by such forward-looking statements as a result of certain factors detailed in our filings with the SEC, including herein. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph.

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included in the Report under “Item 1. Financial Statements”.

 

Overview

 

We are a blank check company incorporated in the Cayman Islands on May 13, 2024, for the purpose of effecting a Business Combination. Our Sponsor is Launch Two Sponsor LLC. We are not limited in our search for target businesses to a particular industry or sector for the purpose of consummating the Business Combination. We are an early stage and emerging growth company and, as such, we are subject to all of the risks associated with early stage and emerging growth companies. We expect to continue to incur significant costs in the pursuit of our acquisition plans. There can be no assurance that our plans to complete a Business Combination, including the NuCube Business Combination, will be successful.

 

Our IPO Registration Statement became effective on October 7, 2024. On October 9, 2024, we consummated our Initial Public Offering of 23,000,000 Units, including 3,000,000 Option Units issued pursuant to the full exercise of the Over-Allotment Option. Each Unit consists of one Public Share and one-half of one Public Warrant. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to us of $230,000,000.

 

Simultaneously with the closing of the Initial Public Offering and pursuant to the Private Placement Warrants Purchase Agreements, we completed the sale of an aggregate of 7,075,000 Private Placement Warrants to the Sponsor and Cantor in the Private Placement at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to us of $7,075,000. Of those 7,075,000 Private Placement Warrants, the Sponsor purchased 4,500,000 Private Placement Warrants and Cantor purchased 2,575,000 Private Placement Warrants. The Private Placement Warrants are identical to the Public Warrants, except as otherwise disclosed in the IPO Registration Statement.

 

Following the closing of the Initial Public Offering and Private Placement, an amount of $231,150,000 from the net proceeds of the Initial Public Offering and the Private Placement was initially placed in the Trust Account located in the United States with Continental acting as trustee. Pursuant to the Trust Agreement, the Trust Account may be invested only (i) in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act with a maturity of 185 days or less, (ii) in any open-ended investment company that holds itself out as a money market fund selected by us meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, (iii) as uninvested cash or (iv) in interest or non-interest bearing demand deposit accounts at a U.S. chartered commercial bank with consolidated assets of $100 billion or more selected Continental that is reasonably satisfactory to us, until the earlier of: (x) the completion of the Business Combination and (y) the distribution of the Trust Account, as described below.

 

Following the approval of the Extension Amendment Proposal (see the section entitled “Recent Developments” below), we have until April 9, 2027, or until such (x) earlier date as our Board may approve or (y) later date as our shareholders may approve, pursuant to the Amended and Restated Articles, to consummate the Business Combination. If we are unable to complete the Business Combination by the end of the Combination Period, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to us to pay taxes, if any, divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our Board, dissolve and liquidate, subject, in each case, to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

 

22

 

 

We may seek to further extend the Combination Period consistent with applicable laws, regulations and stock exchange rules by amending our Amended and Restated Articles. Any such amendment would require the approval of our shareholders, and our Public Shareholders will be provided the opportunity to redeem all or a portion of their Public Shares in connection with the vote on such approval. Such redemptions will decrease the amount held in our Trust Account and our capitalization, and may affect our ability to maintain our listing on Nasdaq. In addition, the Nasdaq Rules currently require SPACs (such as us) to complete their initial Business Combination in accordance with the Nasdaq 36-Month Requirement. If we do not meet the Nasdaq 36-Month Requirement, our securities will likely be subject to suspension of trading and delisting from Nasdaq. Our Sponsor may also, in its discretion, consider selling its interest in our Company to another sponsor entity, which may result in a change to our Management Team.

 

NuCube Business Combination

 

The below subsection describes the material provisions of the NuCube BCA, but does not purport to describe all the terms thereof. This summary of the NuCube BCA is qualified in its entirety by reference to the complete text of the NuCube BCA, a copy of which is filed as Exhibit 2.1 to the NuCube Form 8-Ks and is incorporated by reference herein. Unless otherwise defined herein, the capitalized terms used in this subsection have the same meanings given to them in the NuCube BCA. For a full description of the NuCube BCA and the proposed NuCube Business Combination, please see the NuCube Form 8-Ks and the NuCube Registration Statement.

 

On June 25, 2026, we entered into the NuCube BCA with (i) NuCube, (ii) Merger Sub, (iii) the SPAC Representative and (iv) the Seller Representative. Pursuant to the NuCube BCA and subject to the terms and conditions set forth therein, (i) on or prior to the closing of the NuCube Business Combination (the “Closing,” and the date and time of the Closing, the “Closing Date”), we will de-register from the Register of Companies of the Cayman Islands and transfer by way of continuation out of the Cayman Islands and into the State of Delaware so as to re-domicile as and become a Delaware corporation pursuant to Part 12 of the Companies Act (Revised) of the Cayman Islands and the applicable provisions of the General Corporation Law of the State of Delaware (the “Domestication”); and (ii) following the Domestication, (A) Merger Sub will merge with and into NuCube, with NuCube continuing as the surviving entity (the “Merger”) and, as a result of which, each share of NuCube common stock, par value $0.0001 per share (“NuCube Common Stock”) issued and outstanding immediately prior to the effective time of the Merger (the “Effective Time”) (after giving effect to the Preferred Conversion (as defined below)) shall no longer be outstanding and shall automatically be cancelled and cease to exist in exchange for the right to receive a number of shares of common stock of the Company, par value $0.0001 per share (the “SPAC Common Stock”) equal to the Exchange Ratio (as defined below), and (B) prior to the Effective Time, all outstanding shares of preferred stock of NuCube will either be exchanged for, or convert into, shares of NuCube Common Stock at the applicable conversion ratio (including any accrued or declared but unpaid dividends) in accordance with NuCube’s organizational documents (the “Preferred Conversion”). As a result of the Merger and the NuCube Business Combination, NuCube will become our wholly owned subsidiary, all upon the terms and subject to the conditions set forth in the NuCube BCA.

 

At the Effective Time, each outstanding option (whether vested or unvested) (each, a “NuCube Option”) to purchase NuCube Common Stock will be assumed by and automatically converted into an option for shares of SPAC Common Stock (each, an “Assumed Option”) subject to the same terms, conditions, vesting schedule and other provisions as are currently applicable to such NuCube Options; provided that each Assumed Option will be exercisable for the number of shares of SPAC Common Stock equal to the product of the Exchange Ratio (as defined below) multiplied by the number of shares of NuCube Common Stock subject to the NuCube Option as of immediately prior to the Effective Time, rounded down to the nearest whole number, at an exercise price equal to the quotient of the per share exercise price of the NuCube Option divided by the Exchange Ratio, rounded up to the nearest whole cent.

 

At the Effective Time, each warrant to purchase NuCube Common Stock (each, a “NuCube Warrant”) that is outstanding and unexercised immediately prior to the Effective Time shall be assumed by us and automatically converted into a warrant for shares of SPAC Common Stock (each, an “Assumed Warrant”). Each Assumed Warrant will be subject to the same terms, conditions and other provisions as are currently applicable to the applicable NuCube Warrant; provided that each Assumed Warrant will be exercisable for the number of shares of SPAC Common Stock equal to the product of the Exchange Ratio multiplied by the number of shares of NuCube Common Stock subject to such NuCube Warrant as of immediately prior to the Effective Time, rounded down to the nearest whole number, at an exercise price equal to the quotient of the per share exercise price of such NuCube Warrant divided by the Exchange Ratio, rounded up to the nearest whole cent.

 

Founder Share Conversion

 

On September 30, 2026, in connection with the EGM and the EGM Redemptions, we issued an aggregate of 5,749,999 Class A Ordinary Shares to the Sponsor upon the conversion of an equal number of Class B Ordinary Shares held by the Sponsor in the Founder Share Conversion. The Class A Ordinary Shares issued in the Founder Share Conversion are subject to the same restrictions applicable to the Class B Ordinary Shares prior to the Founder Share Conversion, including, certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial Business Combination, as described in the IPO Registration Statement. Following the Founder Share Conversion, there were 28,749,999 Class A Ordinary Shares issued and outstanding and one Class B Ordinary Share issued and outstanding.

 

23

 

 

The Class A Ordinary Shares issued in the Founder Share Conversion have not been registered under the Securities Act in reliance on the exemption from registration provided by Section 3(a)(9) thereof.

 

Recent Developments

 

Extension of our Combination Period

 

We initially had until October 9, 2026, 24 months from the closing of the Initial Public Offering, to consummate our initial Business Combination.

 

On October 8, 2026, we held the EGM at which our shareholders approved the Extension Amendment Proposal, among other things. In connection with the vote to approve the Extension Amendment Proposal, Public Shareholders holding 18,322,071 Public Shares (after giving effect to withdrawals of redemptions) exercised their right to redeem such Public Shares for cash at a redemption price of approximately $10.84 per Public Share, for an aggregate redemption amount of approximately $198.6 million in the EGM Redemptions. Following the EGM Redemptions, there are 4,677,929 Public Shares currently issued and outstanding.

 

Non-Redemption Agreements

 

In connection with the EGM, we entered into the Non-Redemption Agreements with a number of our shareholders in exchange for such shareholders agreeing (i) not to redeem (or to validly rescind any redemption requests previously made in respect of), and (ii) to vote or consent (in person or by proxy) in favor of the Extension Amendment Proposal at the Meeting, with respect to an aggregate of 4,481,851 Public Shares. In exchange for the foregoing commitments, the Sponsor agreed to transfer to such shareholders an aggregate of 256,061 Class A Ordinary Shares held by the Sponsor per month, for each month of the extension of the Combination Period from October 9, 2026 until April 9, 2027, as needed, with such Class A Ordinary Shares to be transferred upon the closing of the initial Business Combination. Such transfer was conditional on, among other matters, (i) such shareholders not exercising (or having validly rescinded any prior exercise of) their redemption rights with respect to the Non-Redeemed Shares in connection with the EGM, (ii) such shareholders voting or consenting in favor of the Extension Amendment Proposal at the EGM and (iii) the Extension Amendment Proposal being approved at the EGM.

 

Each Non-Redemption Agreement shall terminate on the earliest of (i) the failure of our shareholders to approve the Extension Amendment Proposal at the EGM, (ii) the fulfillment of all obligations of the parties under the Non-Redemption Agreement, (iii) the liquidation or dissolution of our Company, (iv) the mutual written agreement of the parties to the Non-Redemption Agreement, and (v) the exercise by a shareholder of its redemption rights with respect to the Non-Redeemed Shares or the failure by such Investor to vote in favor of the Extension Amendment Proposal at the EGM.

 

The Non-Redemption Agreements were intended to increase the likelihood of the Extension Amendment Proposal being approved by our shareholders at the EGM and were intended to increase the amount of funds that remain in the Trust Account.

 

NuCube BCA First Amendment

 

On October 19, 2026, we entered into the NuCube BCA First Amendment with (a) NuCube, (b) Merger Sub, (c) the SPAC Representative and (d) the Seller Representative to (i) amend Section 7.1(b) of the NuCube BCA to extend the Outside Date (as defined in the NuCube BCA) to January 7, 2027, at 5:00 p.m., Eastern time, subject to the limitations on termination set forth therein, (ii) permit NuCube to enter into securities purchase agreements with investors from time to time prior to the Closing for the issuance and sale of a new series of its preferred stock designated as “Series A-4 Preferred Stock” (such investments, collectively, the “NuCube Financings”), on terms substantially similar to, and not materially more favorable to investors in the aggregate than, the financing terms set forth in Appendix A to the NuCube BCA First Amendment, (iii) amend the definition of Fully Diluted Company Shares (as defined in the NuCube BCA) with the result that the issuance of the Series A-4 Preferred Stock will not reduce the aggregate Merger Consideration (as defined in the NuCube BCA) to be received by holders of NuCube securities before giving effect to such issuance, (iv) increase the share reserve under the Incentive Plan (as defined in the NuCube BCA) from 10% to 12.5% of our outstanding shares after giving effect to the Closing, and (v) require our Company to establish a new employee stock purchase plan with a share reserve equal to 2% of the fully diluted equity capitalization after giving effect to the Closing. Such financing terms provide for the issuance of Series A-4 Preferred Stock at a purchase price of $12.779 per share, with a 1:1 conversion ratio and 50% warrant coverage at an exercise price of $15.887 per warrant share. The NuCube BCA First Amendment further confirms that the NuCube Financings shall constitute Transaction Financings (as defined in the NuCube BCA) for all purposes under the NuCube BCA.

 

Other than as expressly modified pursuant to the NuCube BCA First Amendment, the NuCube BCA remains in full force and effect as originally executed.

 

24

 

 

Results of Operations

 

We have neither engaged in any operations nor generated any revenues to date. Our only activities since May 13, 2024 (inception) through September 30, 2026 have been (i) organizational activities and (ii) activities relating to (x) the Initial Public Offering, (y) identifying and evaluating prospective acquisition candidates and activities in connection with the initial Business Combination and (z) consummating the NuCube Business Combination. We will not generate any operating revenues until after completion of our initial Business Combination. We have generated non-operating income in the form of interest income on investments held in the Trust Account after the Initial Public Offering. We have incurred and expect to continue to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance, among other things), as well as for due diligence expenses.

 

For the three months ended September 30, 2026, we had net income of $1,390,024, which consists of interest income on cash and marketable securities held in the Trust Account of $2,261,800 and interest on operating cash of $14 partially offset by general and administrative costs of $848,355 and interest expense of $23,435.

 

For the nine months ended September 30, 2026, we had net income of $4,507,658, which consists of interest income on cash and marketable securities held in the Trust Account of $6,585,747 and interest on operating cash of $33, partially offset by general and administrative costs of $2,054,687 and interest expense of $23,435.

 

For the three months ended September 30, 2025, we had net income of $2,268,915, which consists of interest income on cash and marketable securities held in the Trust Account of $2,533,302 and interest on operating cash of $152, partially offset by general and administrative costs of $238,860 and unrealized loss on cash and marketable securities held in the Trust Account of $25,679.

 

For the nine months ended September 30, 2025, we had net income of $6,851,780, which consists of interest income on cash and marketable securities held in the Trust Account of $7,473,450 and interest on operating cash of $563, partially offset by general and administrative costs of $622,233.

 

Liquidity, Capital Resources and Going Concern

 

Our liquidity needs through October 9, 2024 were satisfied through (i) a payment of $25,000 from the Sponsor in exchange for the issuance of our Founder Shares and (ii) a loan pursuant to the IPO Promissory Note. Following the Initial Public Offering and the Private Placement, our liquidity needs through September 30, 2026 have been satisfied through (i) the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside the Trust Account and (ii) $750,000 of proceeds advanced by the Sponsor pursuant to the Working Capital Note, which matures on the earliest of the consummation of our initial Business Combination, our winding up and February 17, 2027, subject to our election to extend the maturity.

 

Following the Initial Public Offering, including the full exercise of the Over-Allotment Option, and the Private Placement, a total of $231,150,000 was placed in the Trust Account. We incurred fees of $15,615,485 in the Initial Public Offering, consisting of $4,000,000 of cash underwriting fee, the Deferred Fee of $10,950,000 and $665,485 of other offering costs.

 

For the nine months ended September 30, 2026, cash used in operating activities was $777,728. Net income of $4,507,658 was affected by interest earned on cash and marketable securities held in the Trust Account of $6,585,747 and amortization of debt discount on the Working Capital Note – related party of $23,435. Changes in operating assets and liabilities provided $1,276,926 of cash for operating activities.

 

For the nine months ended September 30, 2025, cash used in operating activities was $435,105. Net income of $6,851,780 was affected by interest earned on marketable securities held in the Trust Account of $7,473,450. Changes in operating assets and liabilities provided $186,565 of cash for operating activities.

 

As of September 30, 2026 and December 31, 2025, we had $222,351 and $250,079 of cash in our operating account, respectively. As of September 30, 2026 and December 31, 2025, we had a working capital deficit of $1,874,756 and working capital surplus of $203,333, respectively. As of September 30, 2026 and December 31, 2025, $18,793,983 and $12,208,236, respectively, of the amount earned on cash and marketable securities held in the Trust Account was available to pay taxes, if any.

 

As of September 30, 2026 and December 31, 2025, we had cash and marketable securities held in the Trust Account of $249,943,983 and $243,358,236, respectively (including approximately $18,793,983 and $12,208,236, respectively, of interest income). We may withdraw interest from the Trust Account to pay taxes, if any. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (which interest shall be net of income taxes payable, if any, and exclude the Deferred Fee), to complete our Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

 

25

 

 

To mitigate the risk that we might be deemed to be an investment company for purposes of the Investment Company Act, which risk increases the longer that we hold investments in the Trust Account, we may, at any time, (based on our Management Team’s ongoing assessment of all factors related to our potential status under the Investment Company Act) instruct Continental to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest-bearing demand deposit account at a bank.

 

As of September 30, 2026 and December 31, 2025, we had cash held outside of the Trust Account of approximately $222,351 and $250,079, respectively. We use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants, or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.

 

IPO Promissory Note

 

Prior to the closing of our Initial Public Offering, our Sponsor agreed to loan us an aggregate of up to $300,000 under the IPO Promissory Note to cover expenses related to the Initial Public Offering. Such loans and advances were non-interest bearing and payable on the earlier of December 31, 2024 or the completion of our Initial Public Offering. The loan of $300,000 was fully repaid upon the consummation of our Initial Public Offering on October 9, 2024. As of September 30, 2026 and December 31, 2025, we had borrowed $0 under the IPO Promissory Note. No additional borrowing is available under the IPO Promissory Note.

 

Working Capital Loans

 

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their affiliates may, but are not obligated to, loan us Working Capital Loans, as may be required. If we complete a Business Combination, we intend to repay such Working Capital Loans. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such Working Capital Loans, but no proceeds from our Trust Account will be used for such repayment. Up to $1,500,000 of such Working Capital Loans may be converted into warrants of the post-Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. Other than as set forth above, the terms of such Working Capital Loans, if any, have not been determined and no other written agreements exist with respect to such Working Capital Loans. As of September 30, 2026 and December 31, 2025, we did not have any borrowings under any Working Capital Loans.

 

Working Capital Note

 

On August 17, 2026, we issued the Working Capital Note to the Sponsor in the principal amount of $848,000. Of the principal, $750,000 was cash advanced to us on August 7, 2026, $48,000 was retained by the Sponsor as an interest reserve, and $50,000 was withheld to reimburse the lender’s fees and expenses. The Working Capital Note bears interest at 8.00% per annum, payable monthly in arrears, with an additional 18.00% upon default. It matures on the earliest of (i) the consummation of the Business Combination, (ii) our winding up, or (iii) February 17, 2027 (the six-month anniversary of issuance). At our election, maturity may be extended for two months and then three months, for fees of 1.0% and 1.5% of principal, respectively, added to principal. Prepayment requires the Sponsor’s consent and a 10% premium. We carry the Working Capital Note at amortized cost; the $98,000 difference between the principal amount and the $750,000 of cash proceeds (consisting of the $48,000 interest reserve and the $50,000 reimbursement of the lender’s fees and expenses) was recorded as a debt discount, which is being amortized to interest expense on a straight-line basis through February 17, 2027, the maturity date of the Working Capital Note. Because the $48,000 interest reserve retained by the Sponsor funds the stated interest for the first six months of the term, no separate interest is accrued for that period. As of September 30, 2026, the net carrying amount was $773,435, consisting of principal of $848,000, less unamortized discount of $74,565. Interest expense, consisting of amortization of the debt discount, for the three and nine months ended September 30, 2026 was $23,435.

 

26

 

 

Going Concern

 

In connection with our assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements—Going Concern”, Management has determined that we currently lack the liquidity we need to sustain operations for a reasonable period of time, which is considered to be at least one year from the date that the unaudited condensed consolidated financial statements and the notes thereto included in this Report under Item 1. “Financial Statements” are issued, as we expect to continue to incur significant costs in pursuit of our acquisition plans. In addition, the Working Capital Note matures on February 17, 2027, which precedes the end of the Combination Period. In addition, Management has determined that if we are unable to complete an initial Business Combination within the Combination Period, then we will cease all operations except for the purpose of liquidating. These conditions raise substantial doubt about our ability to continue as a going concern. Management plans to consummate an initial Business Combination prior to the end of the Combination Period. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after April 9, 2027. There can be no assurance that our plans to raise capital or to consummate an initial Business Combination will be successful.

 

Contractual Obligations

 

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than as follows:

 

Administrative Services Agreement

 

Commencing on October 7, 2024, and until the completion of our Business Combination or liquidation, we reimburse an affiliate of the Sponsor $12,500 per month for office space, utilities, and secretarial and administrative support pursuant to the Administrative Services Agreement. For the three and nine months ended September 30, 2026, we incurred $37,500 and $112,500, respectively, in fees for these services, which amounts are included in general and administrative costs in the unaudited condensed consolidated statements of operations included in this Report under Item 1. “Financial Statements.” As of September 30, 2026, $112,500 of such fees had not been paid and is included in accrued expenses in the condensed consolidated balance sheets included in this Report under Item 1. “Financial Statements.” For the three and nine months ended September 30, 2025, we incurred and paid $37,500 and $112,500, respectively, in fees for these services, which amounts are included in general and administrative costs in the unaudited condensed consolidated statements of operations included in this Report under Item 1. “Financial Statements.”

 

Working Capital Note

 

As of September 30, 2026, $848,000 of principal was outstanding under the Working Capital Note, which bears interest at 8.00% per annum, payable monthly in arrears (with the first six months of interest funded by the $48,000 interest reserve retained by the Sponsor), and matures on the earliest of (i) the consummation of our initial Business Combination, (ii) our winding up and (iii) February 17, 2027, subject to our election to extend the maturity for two months and then an additional three months, for fees of 1.0% and 1.5% of the outstanding principal, respectively, added to the principal. We are also obligated to reimburse the Sponsor for its expenses in connection with obtaining the funds for the Working Capital Note (of which $50,000 was withheld at funding), any extension fees paid by the Sponsor under the Credit Agreement, and certain refinancing, enforcement, reimbursement and indemnification expenses of the Sponsor, subject in each case to a cap of $20,000 per occurrence (other than indemnification obligations), which expense reimbursement obligations in excess of the initial $50,000 will be due upon the maturity date (or earlier event of default). See “—Working Capital Note” above.

 

Underwriting Agreement

 

We granted the Underwriters a 45-day option from the date of the Initial Public Offering to purchase up to an additional 3,000,000 Option Units to cover over-allotments, if any. On October 9, 2024, simultaneously with the closing of the Initial Public Offering, the Underwriters fully exercised their Over-Allotment Option.

 

The Underwriters were paid a cash underwriting discount of $4,000,000 (2.0% of the gross proceeds of the Units offered in the Initial Public Offering, excluding the Option Units). Additionally, the Underwriters are entitled to the Deferred Fee of (i) 4.50% of the gross proceeds of the base Initial Public Offering held in the Trust Account and (ii) 6.50% of the gross proceeds of the Over-Allotment Option, which equates to $10,950,000 in the aggregate following the full exercise of the Over-Allotment Option and is payable to the Underwriters, upon the completion of the initial Business Combination subject to the terms of the Underwriting Agreement.

 

27

 

 

Registration Rights Agreement

 

The holders of (i) the Founder Shares, (ii) the Private Placement Warrants and (iii) any private placement-equivalent warrants issued in connection with the Working Capital Loans, if any (and in each case holders of their underlying securities, as applicable) are entitled to registration rights pursuant to the Registration Rights Agreement, requiring us to register such securities for resale (in the case of the Founder Shares, only after conversion to our Class A Ordinary Shares). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggyback” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require us to register for resale such securities pursuant to Rule 415 under the Securities Act. Cantor may only make a demand on one occasion and only during the five-year period beginning on the effective date of the IPO Registration Statement. In addition, Cantor may participate in a “piggyback” registration only during the seven-year period beginning on the effective date of the IPO Registration Statement. We will bear the expenses incurred in connection with the filing of any such registration statements.

 

Letter Agreement

 

Our Sponsor, directors and officers have entered into the Letter Agreement with us, pursuant to which, they have waived their rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by them if we fail to complete our initial Business Combination within the Combination Period. However, if they acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if we fail to complete our initial Business Combination within the Combination Period.

 

Additionally, pursuant to the Letter Agreement, our Sponsor, directors and officers will not propose any amendment to our Amended and Restated Articles to modify (i) the substance or timing of our obligation to allow redemption in connection with our initial Business Combination or to redeem 100% of our Public Shares if we do not complete our initial Business Combination within the Combination Period or (ii) any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity, unless we provide our Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay our taxes, divided by the number of then outstanding Public Shares.

 

Furthermore, pursuant to the Letter Agreement, our Sponsor, directors, officers have agreed that: (x) the Founder Shares shall be subject to a transfer restrictions of the earlier of (i) one year after the completion of our initial Business Combination or earlier if, subsequent to our initial Business Combination, the closing price of the Class A Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial Business Combination and (ii) the date following the completion of our initial Business Combination on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our shareholders having the right to exchange their Class A Ordinary Shares for cash, securities or other property, (y) the Private Placement Warrants shall be subject to transfer restriction until 30 days after the completion of our initial Business Combination and (z) any Units, Warrants, Ordinary Shares or any other securities convertible into, or exercisable or exchangeable for, any Units, Ordinary Shares, Founder Shares or Warrants were subject to transfer restriction for 180 days following the effective date of the Underwriting Agreement.

 

28

 

 

Credit, Pledge and Consulting Agreements

 

On August 17, 2026, we entered into the Working Capital Note with the Sponsor, pursuant to which the Sponsor loaned $848,000 to us on substantially the same terms as the loan under the certain agreement by and between the Sponsor and SRX Global Inc., (“Lender” and such agreement, the “Credit Agreement”). Pursuant to the Working Capital Note, (i) the Sponsor loaned us the principal amount of $848,000, of which, $750,000 represents the total amount of cash proceeds received by us, which was advanced by the Sponsor to us on August 7, 2026, and the remaining $98,000 of principal consists of amounts retained or applied in connection with the loan, including a $48,000 interest reserve and up to $50,000 for fees and expense reimbursements; (ii) the loan carries an annual interest rate of 8%, payable monthly in arrears, with a default interest rate of an additional 18% (for a total of 26%), subject to the maximum extent permitted by applicable law, and with a $48,000 interest reserve from the proceeds of the loan retained by the Sponsor to pay for the first 6 months of interest; (iii) there is a prepayment penalty of 10% (and in the case of the Working Capital Note, it is prepayable only to the extent with the written consent of the Sponsor); (iv) there is a maturity date for all outstanding obligations under the Working Capital Note of the earliest of (A) the consummation of our initial Business Combination, (B) the effective date of the winding up of our Company and (C) the six-month anniversary of the issuance date of the Working Capital Note (subject to extensions at the sole election of our Company of two months, with a fee added to the principal amount of the loan equal to 1% of the outstanding principal balance of the loan, and, thereafter, an additional three months, with a fee added to the principal amount of the loan equal to 1.5% of the outstanding principal balance of the loan), (or if earlier, upon an event of default); and (v) there is an obligation to reimburse the Sponsor for its expenses in connection with obtaining the funds for the loan under the Working Capital Note (of which $50,000 was withheld at the funding of the loan to reimburse the Lender for certain of its fees and expenses under the Credit Agreement), any extension fees paid by the Sponsor under the Credit Agreement, and for any expenses of the Sponsor in connection with any refinancing of the debt or the enforcement of the Working Capital Note and for any reimbursement or indemnification obligations of the Sponsor under the Credit Agreement and related documents, subject in each case to a cap of $20,000 per occurrence (other than with respect to indemnification obligations), which expense reimbursement obligations in excess of the initial $50,000 will be due upon the maturity date (or earlier event of default). In light of our limited cash balance at year end, the Board and Management determined to secure additional working capital through the Working Capital Note to fund past and ongoing operational expenses.

 

In connection with the Credit Agreement, the Sponsor also entered into a Pledge Agreement with the Lender (the “Pledge Agreement”), pursuant to which the Sponsor pledged 2,932,500 Founder Shares (which were converted into Class A Ordinary Shares on September 30, 2026) (representing approximately 51% of the Founder Shares owned by the Sponsor), together with any proceeds thereof (the “Pledged Collateral”), as collateral to secure the obligations under the Credit Agreement. The Credit Agreement also provides that, upon the consummation of the initial Business Combination, the Sponsor will transfer and assign to the Lender 150,000 Founder Shares (or any shares of a successor public company issued in exchange therefor in connection with the Business Combination) as partial consideration for the loan (the “Consideration Shares”). The Consideration Shares are included in the Pledged Collateral. The loan under the Credit Agreement is non-recourse to the Sponsor, and the Lenders’ sole recourse in the event of a default is to foreclose upon such Pledged Collateral, which would remain subject to our governing documents and applicable lock-up arrangements, including the terms of the Letter Agreement. The Sponsor is required to use the proceeds of the loan under the Credit Agreement to fund loans to us to pay for our expenses, including transaction expenses related to the Business Combination, amounts previously owed for prior Business Combination efforts and for administrative expenses. The Credit Agreement includes events of default for the Company’s failure to file with the SEC by a certain agreed upon date a proxy statement to call for a shareholder meeting to extend the Combination Period or for our failure to enter into a definitive Business Combination agreement with a target company or business prior to a certain agreed upon date. However, the Credit Agreement and Pledge Agreement solely bind the Sponsor and do not restrict our actions.

 

On August 17, 2026, the Sponsor also entered into a Consulting Services and Share Purchase Agreement (the “Consulting Agreement”) with Strategic Capital Advisories (“SCA”), pursuant to which SCA agreed to provide certain consulting services to the Sponsor and, on behalf of the Sponsor, to us in connection with our initial Business Combination. As consideration for such services, the Sponsor agreed to sell and transfer to SCA, concurrently with the consummation of our initial Business Combination, 350,000 Founder Shares at a purchase price of $0.04 per share (the “Consulting Shares”). The Consulting Shares are included in the Pledged Collateral.

 

In connection with the aforementioned agreements, we entered into a waiver letter with (i) the Sponsor, (ii) Cantor, as representative of the Underwriters and (iii) NuCube, pursuant to which the restrictions on transfers contained in the Letter Agreement were waived solely to permit the pledge of the Pledged Collateral under the Credit Agreement and the Pledge Agreement, the transfer and assignment of the Consideration Shares to the Lender pursuant to the Credit Agreement, and the sale and transfer of the Consulting Shares to SCA pursuant to the Consulting Agreement, in each case subject to the terms of the Letter Agreement.

 

29

 

 

Critical Accounting Estimates

 

The preparation of the unaudited condensed consolidated financial statements and notes thereto included in this Report under Item 1. “Financial Statements” in conformity with GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities, income and expenses, and the disclosure of contingent assets and liabilities, in our unaudited condensed consolidated financial statements. These accounting estimates require the use of assumptions about matters, some of which are highly uncertain at the time of estimation. Management bases its estimates on historical experience and on various other assumptions it believes to be reasonable under the circumstances, the results of which form the basis for making judgments, and we evaluate these estimates on an ongoing basis. To the extent actual experience differs from the assumptions used, our unaudited condensed consolidated financial statements and notes thereto included in this Report under Item 1. “Financial Statements” could be materially affected. We believe that the following accounting policies involve a higher degree of judgment and complexity: using a valuation, we estimated the fair value of the Public Warrants as of the Initial Public Offering. Other than estimating the value of the Public Warrants, we did not have any other critical accounting estimates as of September 30, 2026.

  

Recent Accounting Standards

 

In November 2024, the FASB issued ASU Topic 2024-03, “Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses” (“ASU 2024-03”), requiring public entities to disclose additional information about specific expense categories in the notes to the unaudited condensed consolidated financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. We are currently evaluating the impact of adopting ASU 2024-03.

 

Management does not believe that there are any other recently issued, but not yet effective, accounting standards, which, if currently adopted, would have a material effect on the unaudited condensed consolidated financial statements and notes thereto included in this Report under Item 1. “Financial Statements”.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this Item.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Report, is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures are also designed with the objective of ensuring that such information is accumulated and communicated to our Management, including our Certifying Officers, as appropriate, to allow timely decisions regarding required disclosure. Under the supervision and with the participation of our Management, including our Certifying Officers, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on the foregoing, our Certifying Officers concluded that our disclosure controls and procedures were effective as of September 30, 2026.

 

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. 

 

Changes in Internal Control over Financial Reporting

 

There have been no changes to our internal control over financial reporting during the quarterly period ended September 30, 2026 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

30

 

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

To the knowledge of our Management Team, there is no material litigation currently pending or contemplated against us, any of our subsidiaries, any of our officers or directors in their capacity as such or against any of our property.

  

Item 1A. Risk Factors.

 

As a smaller reporting company under Rule 12b-2 of the Exchange Act, we are not required to include risk factors in this Report. However, for detailed descriptions of the risks relating to our Company, see the section titled “Risk Factors” contained in our (i) IPO Registration Statement, (ii) 2024 Annual Report, (iii) 2025 Annual Report, (iv) 2025 First Quarter Form 10-Q, (v) 2025 Second Quarter Form 10-Q and (vi) Definitive Proxy Statement on Schedule 14A, as filed with the SEC on September 14, 2026. As of the date of this Report, there have been no material changes with respect to those risk factors, other than as set forth below. Any of these previously disclosed risk factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risks not presently known to us or that we currently deem immaterial that may also affect our ability to consummate an initial Business Combination. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.

 

For risks related to NuCube and the NuCube Business Combination, please see the NuCube Registration Statement.

 

Our Public Shareholders’ exercise of redemption rights with respect to a large number of Public Shares in the EGM Redemptions may affect our ability to complete an initial Business Combination in the most desirable manner that will optimize the capital structure of the combined company, or at all.

 

Over the past two years, the redemption rate of shares held by Public Shareholders of SPACs at the time of a shareholder meeting that approves an amendment to the articles of the SPAC or the initial Business Combination of the SPAC has been very high, thereby increasing the likelihood that we, too, may be subject to significant redemptions that may affect our ability to complete an initial Business Combination. In addition, the amount of the Deferred Fee payable to the underwriters in connection with our Initial Public Offering will not be reduced for any Public Shares that are redeemed in connection with an extension of the Combination Period or a Business Combination. If we are able to consummate an initial Business Combination, the per-share value of Public Shares held by non-redeeming Public Shareholders following the Business Combination will reflect our obligation to pay, and the payment of, the Deferred Fee.

 

In connection with the EGM, 18,322,071 Public Shares were redeemed at a price per Public Share of approximately $10.84, thereby reducing the number of outstanding Public Shares to 4,677,929, and reducing the total amount held in the Trust Account by $198.6 million.

 

Due to the high rates of redemptions of Public Shares in connection with shareholder votes on extensions or Business Combinations of SPACs, we may need to rely upon significant PIPE or other outside financing to provide cash to our post-Business Combination company. Obtaining financing in connection with initial Business Combinations of SPACs has in recent times been very difficult, with many financings available only on terms that are onerous to the surviving company of the Business Combination. The failure to secure additional financing on reasonable terms could have a material adverse effect on the continued development or growth of the target business. None of the Sponsor or our other shareholders is required to provide any financing to us in connection with or after our initial Business Combination. Raising additional third-party financing may involve dilutive equity issuances or the incurrence of indebtedness at higher than desirable levels or on onerous terms. The above considerations may limit our ability to complete a Business Combination in the most desirable manner that will optimize the capital structure of the combined company, or at all. If we are unable to complete an initial Business Combination, our Public Shareholders may only receive approximately $10.92 per Public Share on the liquidation of our Trust Account, as of November 12, 2026, and our Warrants will expire worthless. In certain circumstances, our Public Shareholders may receive less than $10.92 per share on the redemption of their Public Shares.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

Unregistered Sales of Equity Securities

 

On September 30, 2026, in connection with the EGM and the EGM Redemptions, we issued an aggregate of 5,749,999 Class A Ordinary Shares to Sponsor upon the conversion of an equal number of Class B Ordinary Shares held by the Sponsor in the Founder Share Conversion. The Class A Ordinary Shares issued in the Founder Share Conversion are subject to the same restrictions applicable to the Class B Ordinary Shares prior to the Founder Share Conversion, including, certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial Business Combination, as described in the IPO Registration Statement. Following the Founder Share Conversion, there were 28,749,999 Class A Ordinary Shares issued and outstanding and one Class B Ordinary Share issued and outstanding.

 

The Class A Ordinary Shares issued in the Founder Share Conversion have not been registered under the Securities Act in reliance on the exemption from registration provided by Section 3(a)(9) thereof.

 

31

 

 

Use of Proceeds

 

There were no offerings of registered securities and therefore no planned use of proceeds from such offerings during the quarterly period covered by this Report. For a description of the use of proceeds generated in our Initial Public Offering and the Private Placement, see Part II, Item 2 of our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2024, as filed with the SEC on November 19, 2024. There has been no material change in the planned use of proceeds from our Initial Public Offering and Private Placement as described in the IPO Registration Statement. The specific investments in our Trust Account may change from time to time.

 

To mitigate the risk that we might be deemed to be an investment company for purposes of the Investment Company Act, which risk increases the longer that we hold investments in the Trust Account, we may, at any time, (based on our Management Team’s ongoing assessment of all factors related to our potential status under the Investment Company Act) instruct Continental to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest-bearing demand deposit account at a bank.

 

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

 

There were no purchases of our equity securities by us or an affiliate during the quarterly period covered by this Report. However, on October 8, 2026, we held the EGM at which our shareholders approved the Extension Amendment Proposal, among other things. In connection with the vote to approve the Extension Amendment Proposal, Public Shareholders holding 18,322,071 Public Shares (after giving effect to withdrawals of redemptions) exercised their right to redeem such Public Shares for cash at a redemption price of approximately $10.84 per Public Share, for an aggregate redemption amount of approximately $198.6 million in the EGM Redemptions. Following the EGM Redemptions, there are 4,677,929 Public Shares currently issued and outstanding.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

  

Item 5. Other Information.

 

Director Nominations

 

There have been no material changes to the procedures by which our security holders may recommend nominees to our Board since we reported such procedures in the 2025 Annual Report.

 

Trading Arrangements

 

During the quarterly period ended September 30, 2026, none of our directors or officers (as defined in Rule 16a-1(f) promulgated under the Exchange Act) adopted or terminated any “Rule 10b5-1 trading arrangement” or any “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

 

Additional Information

 

None.

 

32

 

 

Item 6. Exhibits.

 

The following exhibits are filed as part of, or incorporated by reference into, this Report.

 

No.   Description of Exhibit
10   Working Capital Note dated as of August 17, 2026 by and between the Company and the Sponsor. (1)
     
31.1   Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
     
31.2   Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
     
32.1   Certification of the Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
     
32.2   Certification of the Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
     
101.INS   Inline XBRL Instance Document.*
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document.*
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.*
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.*
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.*
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.*
     
104   Cover Page Interactive Data File (Embedded as Inline XBRL document and contained in Exhibit 101).*

 

* Filed herewith.
   
** Furnished herewith.
   
(1) Incorporated by reference to the Company’s Current Report on Form 8-K, as filed with the SEC on August 18, 2026.

 

33

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Dated: November 13, 2026 Launch Two Acquisition Corp.
   
  By: /s/ Jay McEntee
  Name: Jay McEntee
  Title: Chief Executive Officer
    (Principal Executive Officer)

 

Dated: November 13, 2026 By: /s/ Jurgen van de Vyver
  Name: Jurgen van de Vyver
  Title: Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

34

 

Keep reading